00000000|MMI|16.10|Pulmonary Embolism|C0034065|[dsyn]|["PULMONARY EMBOLISM"-tx-1-"pulmonary embolism"-noun-0]|TX|66/18|C08.381.746;C14.907.355.350.700
00000000|MMI|3.65|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|95/14|
00000000|MMI|3.65|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|95/14|
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|121/13|
00000000|MMI|3.64|10 - 12|C3843787|[fndg]|["10 - 12"-tx-1-"10 12"-fraction-0]|TX|41/2,52/2|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.46|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|89/3|
00000000|MMI|3.46|Discontinued|C1444662|[fndg]|["DIS"-tx-1-"DIS"-noun-0]|TX|89/3|
00000000|MMI|320.82|Portugal|C0032729|[geoa]|["PO"-tx-12-"PO"-noun-0,"PO"-tx-9-"PO"-noun-0,"PO"-tx-8-"PO"-noun-0,"PO"-tx-6-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0]|TX|2407/2;[1831/2],[1866/2];[1475/2],[1691/2];[1033/2],[1175/2],[1330/2];[381/2],[467/2],[576/2],[650/2],[865/2],[921/2]|Z01.542.727
00000000|MMI|175.60|Mongolia|C0026410|[geoa]|["MG"-tx-12-"MG"-noun-0,"MG"-tx-9-"MG"-noun-0,"MG"-tx-8-"MG"-noun-0,"MG"-tx-6-"MG"-noun-0,"MG"-tx-4-"MG"-noun-0]|TX|2404/2;[1828/2],[1863/2];1688/2;[1172/2],[1219/2],[1327/2];[378/2],[464/2],[776/2],[918/2]|Z01.252.474.651
00000000|MMI|114.93|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-62-"DISCHARGE"-noun-0,"Discharge"-tx-59-"DISCHARGE"-noun-0,"Discharged"-tx-18-"discharged"-verb-0,"Discharge"-tx-15-"DISCHARGE"-noun-0,"Patient Discharge"-tx-2-"DISCHARGE PATIENT"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5773/9;5579/9;3596/10;2713/9;121/17;38/9|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|113.41|Oral|C0442027|[spco]|["PO"-tx-12-"PO"-noun-0,"PO"-tx-9-"PO"-noun-0,"PO"-tx-8-"PO"-noun-0,"PO"-tx-6-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0]|TX|2407/2;[1831/2],[1866/2];[1475/2],[1691/2];[1033/2],[1175/2],[1330/2];[381/2],[467/2],[576/2],[650/2],[865/2],[921/2]|
00000000|MMI|110.17|Obesity|C0028754|[dsyn]|["OBESE"-tx-32-"obese"-adj-0,"OBESE"-tx-24-"obese"-adj-0,"OBESITY"-tx-15-"obesity"-noun-0]|TX|4376/5;4148/5;[3030/7],[3040/7]|C18.654.726.500;C23.888.144.699.500;E01.370.600.115.100.160.120.699.500;G07.100.100.160.120.699.500
00000000|MMI|95.93|Pain|C0030193|[sosy]|["PAIN"-tx-58-"pain"-noun-0,"PAIN"-tx-56-"Pain"-noun-0,"PAIN"-tx-55-"PAIN"-noun-0,"PAIN"-tx-24-"pain"-noun-0,"PAIN"-tx-16-"Pain"-noun-0,"PAIN"-tx-4-"Pain"-noun-0]|TX|5549/4;5261/4;5214/4;4167/4;3462/4;661/4|C10.597.617;C23.888.592.612;F02.830.816.444;G11.561.600.810.444
00000000|MMI|92.81|Rabbi|C0684010|[prog]|["R."-tx-31-"R"-noun-0,"R."-tx-29-"r"-noun-0,"R."-tx-24-"R"-noun-0,"R."-tx-15-"R"-noun-0,"R."-tx-9-"R"-noun-0,"R."-tx-6-"R"-noun-0,"R."-tx-4-"R"-noun-0]|TX|4335/1;4308/1;4104/1;3178/1;1961/1;1436/1;994/1|M01.526.799.500
00000000|MMI|85.33|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-58-"treatment"-noun-0,"treatment"-tx-57-"Treatment"-noun-0,"treatment"-tx-15-"Treatment"-noun-0,"treatment"-tx-12-"Treatment"-noun-0]|TX|5398/9;5306/9;2869/9;2347/9|x.x.x.x.x.x.x
00000000|MMI|73.63|Lovenox|C0728963|[orch,phsu]|["Lovenox"-tx-59-"lovenox"-noun-0,"Lovenox"-tx-57-"Lovenox"-noun-0,"Lovenox"-tx-42-"lovenox"-noun-0,"Lovenox"-tx-6-"LOVENOX"-noun-0]|TX|5624/7;5321/7;4624/7;1193/7|D09.698.373.400.300.200
00000000|MMI|64.47|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-15-"DIAGNOSIS"-noun-0,"diagnosis"-tx-12-"Diagnosis"-noun-0]|TX|[2673/9],[2807/9];2300/9|x.x.x.x.x.x.x
00000000|MMI|56.49|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-12-"MG"-noun-0,"Mg++"-tx-9-"MG"-noun-0,"Mg++"-tx-8-"MG"-noun-0,"Mg++"-tx-6-"MG"-noun-0,"Mg++"-tx-4-"MG"-noun-0,"Mg+2"-tx-4-"MG 2"-noun-0]|TX|2404/2;[1828/2],[1863/2];1688/2;[1172/2],[1219/2],[1327/2];[378/2],[464/2],[776/2],[918/2];378/2,405/1|
00000000|MMI|55.57|Aranesp|C1134440|[aapp,phsu]|["Aranesp"-tx-47-"aranesp"-noun-0,"Aranesp"-tx-45-"Aranesp"-noun-0,"Aranesp"-tx-12-"ARANESP"-noun-0]|TX|4880/7;4775/7;2125/7|D12.776.395.240.150.500
00000000|MMI|55.03|Hypercholesterolemia|C0020443|[dsyn]|["HYPERCHOLESTEROLEMIA"-tx-52-"Hypercholesterolemia"-noun-0,"Elevated Cholesterol"-tx-15-"elevated cholesterol"-noun-0,"HYPERCHOLESTEROLEMIA"-tx-15-"hypercholesterolemia"-noun-0]|TX|5085/20;2936/20;2913/20|C18.452.584.500.500.396
00000000|MMI|54.33|Protons|C0033727|[elii]|["H+"-tx-9-"H"-noun-0,"H+"-tx-6-"H"-noun-0,"H+"-tx-4-"H"-noun-0]|TX|1959/1;1434/1;992/1|D01.248.497.300.459.700;D01.268.406.750;D01.362.340.750;G01.249.765
00000000|MMI|53.70|Aspirin|C0004057|[orch,phsu]|["ASA"-tx-48-"ASA"-noun-0,"Acetylsalicylic Acid"-tx-4-"ACETYLSALICYLIC ACID"-noun-0]|TX|4951/3;354/20|D02.455.426.559.389.657.410.595.176
00000000|MMI|53.57|Guaifenesin|C0018305|[orch,phsu]|["Guaiphenesin"-tx-50-"guaifenesin"-noun-0,"Guaiphenesin"-tx-4-"GUAIFENESIN"-noun-0]|TX|5027/11;583/11|D02.355.601.536.400;D02.355.726.453.400;D02.455.426.559.389.657.166.453.400;D02.455.426.559.389.657.654.453.400
00000000|MMI|50.25|Dominican Republic|C0013014|[geoa]|["DR"-tx-14-"Dr"-noun-0,"DR"-tx-13-"Dr"-noun-0,"DR"-tx-12-"Dr"-noun-0]|TX|2608/2;2558/2;2540/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|47.80|Sertraline Hydrochloride|C0600526|[orch,phsu]|["sertraline hcl"-tx-12-"SERTRALINE HCL"-noun-0,"sertraline hcl"-tx-6-"SERTRALINE HCL"-noun-0]|TX|2001/14;1077/14|D02.092.705.800;D02.455.426.559.847.638.845.800;D04.615.638.845.800
00000000|MMI|47.03|Milligram percent|C1960952|[qnco]|["mg %"-tx-12-"MG"-noun-0,"mg %"-tx-9-"MG"-noun-0,"mg %"-tx-8-"MG"-noun-0,"mg %"-tx-6-"MG"-noun-0,"mg %"-tx-4-"MG"-noun-0]|TX|2404/2;[1828/2],[1863/2];1688/2;[1172/2],[1219/2],[1327/2];[378/2],[464/2],[776/2],[918/2]|
00000000|MMI|47.03|mg/dL|C0439269|[qnco]|["mg%"-tx-12-"MG"-noun-0,"mg%"-tx-9-"MG"-noun-0,"mg%"-tx-8-"MG"-noun-0,"mg%"-tx-6-"MG"-noun-0,"mg%"-tx-4-"MG"-noun-0]|TX|2404/2;[1828/2],[1863/2];1688/2;[1172/2],[1219/2],[1327/2];[378/2],[464/2],[776/2],[918/2]|
00000000|MMI|46.25|Nifedipine|C0028066|[orch,phsu]|["NIFEDIPINE"-tx-49-"nifedipine"-noun-0,"NIFEDIPINE"-tx-8-"NIFEDIPINE"-noun-0]|TX|4975/10;[1630/10],[1664/10]|D03.383.725.203.540
00000000|MMI|46.19|Asthma|C0004096|[dsyn]|["-- Asthma"-tx-50-"Asthma"-noun-0,"-- Asthma"-tx-15-"asthma"-noun-0]|TX|4996/6;[2984/6],[2993/6]|C08.127.108;C08.381.495.108;C08.674.095;C20.543.480.680.095
00000000|MMI|45.92|Treatment Protocols|C0040808|[topp]|["Regimen"-tx-56-"regimen"-noun-0,"Regimen"-tx-54-"regimen"-noun-0,"Treatment Regimen"-tx-47-"treatment regimen"-noun-0]|TX|5266/7;5179/7;4854/17|E02.183;N05.715.360.775.225
00000000|MMI|41.82|Coding|C0009219|[ocac]|["code"-tx-4-"CODE"-noun-0,"code"-tx-4-"code"-noun-0]|TX|280/4;298/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|41.34|Physicians|C0031831|[prog]|["DR"-tx-14-"Dr"-noun-0,"DR"-tx-13-"Dr"-noun-0,"DR"-tx-12-"Dr"-noun-0]|TX|2608/2;2558/2;2540/2|M01.526.485.810;N02.360.810
00000000|MMI|39.62|Override|C1547671|[acty]|["Override"-tx-12-"override"-verb-0,"Override"-tx-9-"Override"-verb-0,"Override"-tx-9-"overridden"-noun-0,"Override"-tx-8-"override"-verb-0,"Override"-tx-6-"Override"-verb-0,"Override"-tx-6-"override"-verb-0,"Override"-tx-4-"Override"-verb-0]|TX|2112/8;1911/8;1899/10;1572/8;[1369/8],[1386/8];1125/8;[927/8],[944/8]|
00000000|MMI|36.80|Constipation|C0009806|[sosy]|["CONSTIPATION"-tx-54-"constipation"-noun-0,"CONSTIPATION"-tx-23-"constipation"-noun-0,"CONSTIPATION"-tx-4-"Constipation"-noun-0]|TX|5191/12;4006/12;751/12|C23.888.821.150
00000000|MMI|36.44|Flovent|C0720466|[orch,phsu]|["Flovent"-tx-50-"flovent"-noun-0,"Flovent"-tx-6-"FLOVENT"-noun-0]|TX|5017/7;1229/7|D04.808.054.079.129.114
00000000|MMI|36.04|Seroquel|C0287163|[orch,phsu]|["Seroquel"-tx-55-"seroquel"-noun-0,"Seroquel"-tx-6-"SEROQUEL"-noun-0]|TX|5234/8;1300/8|D02.886.680.702.500.500;D03.494.276.500
00000000|MMI|36.02|Quetiapine fumarate|C0724680|[orch,phsu]|["QUETIAPINE FUMARATE"-tx-12-"QUETIAPINE FUMARATE"-noun-0,"QUETIAPINE FUMARATE"-tx-8-"QUETIAPINE FUMARATE"-noun-0]|TX|2059/19;1519/19|D02.886.680.702.500.500;D03.494.276.500
00000000|MMI|34.30|Subject Continuance|C2826258|[evnt]|["CONT"-tx-59-"cont"-noun-0,"CONT"-tx-55-"Cont"-noun-0,"CONT"-tx-54-"Cont"-noun-0,"CONT"-tx-52-"cont"-noun-0,"CONT"-tx-51-"cont"-noun-0,"CONT"-tx-49-"cont"-noun-0,"CONT"-tx-48-"cont"-noun-0,"CONT"-tx-47-"cont"-noun-0,"CONT"-tx-44-"Cont"-noun-0]|TX|5619/4;5220/4;5168/4;5108/4;5058/4;4970/4;4946/4;4899/4;4747/4|
00000000|MMI|32.14|Physical therapy (field)|C0699718|[bmod]|["physical therapy"-tx-59-"physical therapy"-noun-0,"PT"-tx-43-"pt"-noun-0,"PT"-tx-23-"pt"-noun-0,"PT"-tx-22-"Pt"-noun-0,"PT"-tx-21-"Pt"-noun-0,"PT"-tx-20-"pt"-noun-0,"PT"-tx-18-"pt"-noun-0,"PT"-tx-4-"pt"-noun-0]|TX|5647/16;4705/2;3999/2;3927/2;3859/2;3768/2;3589/2;832/2|
00000000|MMI|30.52|Reading (activity)|C0034754|[dora]|["Read"-tx-19-"read"-verb-0,"Read"-tx-18-"read"-verb-0]|TX|3678/4;3566/4|L01.143.506.423.557
00000000|MMI|30.36|Lipitor|C0593906|[orch,phsu]|["Lipitor"-tx-52-"lipitor"-noun-0,"Lipitor"-tx-12-"LIPITOR"-noun-0]|TX|5113/7;2376/7|D03.383.129.578.075;D10.251.450.200
00000000|MMI|30.34|Pulmonary Embolism|C0034065|[dsyn]|["PULMONARY EMBOLISM"-tx-15-"pulmonary embolism"-noun-0]|TX|[2684/18],[2782/18]|C08.381.746;C14.907.355.350.700
00000000|MMI|30.33|Togo|C0040363|[geoa]|["TO"-tx-26-"to"-adv-0,"TO"-tx-21-"to"-adv-0]|TX|4249/2;3873/2|Z01.058.290.190.800
00000000|MMI|30.33|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-26-"to"-adv-0,"TO"-tx-21-"to"-adv-0]|TX|4249/2;3873/2|D08.811.520.224.800
00000000|MMI|30.18|Right|C0205090|[spco]|["R-"-tx-31-"R"-noun-0,"R-"-tx-29-"r"-noun-0,"R-"-tx-24-"R"-noun-0,"R-"-tx-15-"R"-noun-0,"Right side"-tx-15-"right side"-noun-0,"R-"-tx-9-"R"-noun-0,"R-"-tx-6-"R"-noun-0,"R-"-tx-4-"R"-noun-0]|TX|4335/1;4308/1;4104/1;3178/1;3378/10;1961/1;1436/1;994/1|
00000000|MMI|30.15|Albuterol|C0001927|[orch,phsu]|["ALBUTEROL"-tx-50-"albuterol"-noun-0,"ALBUTEROL"-tx-4-"ALBUTEROL"-noun-0]|TX|5005/9;387/9|D02.033.100.291.057;D02.092.063.291.057;D02.092.471.683.061
00000000|MMI|30.01|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-8-"Food/Drug Interaction"-noun-0,"Interaction, Food-Drug"-tx-4-"Food/Drug Interaction"-noun-0]|TX|1717/21;504/21|G07.690.773.968.511
00000000|MMI|29.96|Saint Kitts and Nevis|C0282380|[geoa]|["SC"-tx-12-"SC"-noun-0,"SC"-tx-6-"SC"-noun-0]|TX|2162/2;1222/2|Z01.107.084.900.787;Z01.639.880.787
00000000|MMI|29.96|Fluorides|C0016327|[inch,phsu]|["F-"-tx-59-"f"-noun-0,"F-"-tx-15-"F"-adj-0]|TX|5637/1;3232/1|D01.248.497.158.380;D01.303.350.300
00000000|MMI|28.85|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-49-"HTN"-noun-0,"HTN"-tx-15-"htn"-noun-0,"HYPERTENSION"-tx-15-"hypertension"-noun-0]|TX|4964/3;2961/3;2967/12|C14.907.489
00000000|MMI|28.24|Citrus paradisi|C0947567|[plnt]|["grapefruit"-tx-8-"grapefruit"-noun-0]|TX|1757/10|B01.650.940.800.575.100.875.177.538
00000000|MMI|27.51|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-43-"pt"-noun-0,"PT"-tx-23-"pt"-noun-0,"PT"-tx-22-"Pt"-noun-0,"PT"-tx-21-"Pt"-noun-0,"PT"-tx-20-"pt"-noun-0,"PT"-tx-18-"pt"-noun-0,"PT"-tx-4-"pt"-noun-0]|TX|4705/2;3999/2;3927/2;3859/2;3768/2;3589/2;832/2|
00000000|MMI|27.33|Dyspnea|C0013404|[sosy]|["SHORTNESS OF BREATH"-tx-58-"shortness of breath"-noun-0,"SOB"-tx-22-"SOB"-noun-1]|TX|5557/19;3937/3|C08.618.326;C23.888.852.371
00000000|MMI|26.71|Obesity, Morbid|C0028756|[dsyn]|["Morbid Obesity"-tx-53-"Morbid obesity"-noun-0]|TX|5129/14|C18.654.726.500.700;C23.888.144.699.500.500;E01.370.600.115.100.160.120.699.500.500;G07.100.100.160.120.699.500.500
00000000|MMI|25.56|R prime|C2603358|[clna]|["R'"-tx-31-"R"-noun-0,"R'"-tx-29-"r"-noun-0,"R'"-tx-24-"R"-noun-0,"R'"-tx-15-"R"-noun-0,"R'"-tx-9-"R"-noun-0,"R'"-tx-6-"R"-noun-0,"R'"-tx-4-"R"-noun-0]|TX|4335/1;4308/1;4104/1;3178/1;1961/1;1436/1;994/1|
00000000|MMI|25.31|Heme|C0018966|[bacs,orch]|["Haem"-tx-42-"HEME"-noun-0]|TX|4592/4|D03.383.129.578.840.500.640.587;D03.549.909.500.640.587;D04.345.783.500.640.587;D23.767.727.640.587
00000000|MMI|25.31|Sertraline|C0074393|[orch,phsu]|["SERTRALINE"-tx-4-"SERTRALINE"-noun-0]|TX|902/10|D02.092.705.800;D02.455.426.559.847.638.845.800;D04.615.638.845.800
00000000|MMI|25.09|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-60-"M.D"-noun-0,"M.D."-tx-10-"M.D"-noun-0,"M.D."-tx-7-"M.D"-noun-0,"M.D."-tx-5-"M.D"-noun-0,"M.D."-tx-3-"M.D"-noun-0]|TX|5716/3;1966/3;1441/3;999/3;275/3|
00000000|MMI|24.25|Panama|C0030266|[geoa]|["PM"-tx-62-"PM"-noun-0,"PM"-tx-2-"PM"-adj-0]|TX|5756/2;161/2|Z01.107.169.772
00000000|MMI|24.07|phosphoethanolamine|C0070939|[bacs,orch]|["PE"-tx-57-"PE"-noun-0,"PE"-tx-42-"PE"-noun-0]|TX|5333/2;4598/2|x.x.x.x
00000000|MMI|23.83|Zoloft|C0284660|[orch,phsu]|["Zoloft"-tx-4-"ZOLOFT"-noun-0]|TX|893/6|D02.092.705.800;D02.455.426.559.847.638.845.800;D04.615.638.845.800
00000000|MMI|23.72|Residual volume|C0035190|[clna]|["RV"-tx-40-"RV"-noun-0]|TX|4505/2|E01.370.386.700.485.750.275.650;G09.772.850.390.820
00000000|MMI|23.71|Hippocampus Proper|C3887642|[bpoc]|["CA"-tx-15-"ca"-noun-0]|TX|3104/2|A08.186.211.464.405;A08.186.211.730.885.287.500.345
00000000|MMI|22.38|Garbage|C0017095|[eehu]|["Refuse"-tx-4-"refuse"-verb-0]|TX|839/6|N06.850.860.510.900.600.400
00000000|MMI|22.38|Walking (activity)|C0080331|[dora]|["Walking"-tx-12-"Walking"-noun-0]|TX|2491/7|G11.427.590.530.568.900;G11.427.590.530.698.277.937;I03.350.937;I03.450.642.845.940
00000000|MMI|21.51|Order (action)|C1705178|[acty]|["Order"-tx-62-"ORDERS"-verb-0,"Order"-tx-12-"order"-noun-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5783/6;2265/5;1458/5;1016/5;204/5;48/6|
00000000|MMI|21.51|Order (arrangement)|C1705176|[qlco]|["Order"-tx-62-"ORDERS"-verb-0,"Order"-tx-12-"order"-noun-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5783/6;2265/5;1458/5;1016/5;204/5;48/6|
00000000|MMI|21.51|Order (document)|C1705175|[inpr]|["Order"-tx-62-"ORDERS"-verb-0,"Order"-tx-12-"order"-noun-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5783/6;2265/5;1458/5;1016/5;204/5;48/6|
00000000|MMI|21.51|Order (taxonomic)|C1705177|[clas]|["Order"-tx-62-"ORDERS"-verb-0,"Order"-tx-12-"order"-noun-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5783/6;2265/5;1458/5;1016/5;204/5;48/6|
00000000|MMI|21.51|Permutation|C1882348|[qlco]|["Order"-tx-62-"ORDERS"-verb-0,"Order"-tx-12-"order"-noun-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5783/6;2265/5;1458/5;1016/5;204/5;48/6|
00000000|MMI|21.51|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-62-"ORDERS"-verb-0,"ORDER"-tx-12-"order"-noun-0,"ORDER"-tx-8-"order"-noun-0,"ORDER"-tx-6-"order"-noun-0,"ORDER"-tx-2-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|5783/6;2265/5;1458/5;1016/5;204/5;48/6|
00000000|MMI|21.44|Arthritis|C0003864|[dsyn]|["ARTHRITIS"-tx-15-"arthritis"-noun-0]|TX|[3004/9],[3016/9]|C05.550.114
00000000|MMI|21.07|Pain NOS Adverse Event|C1962977|[fndg]|["Pain NOS"-tx-58-"pain"-noun-0,"Pain NOS"-tx-56-"Pain"-noun-0,"Pain NOS"-tx-55-"PAIN"-noun-0,"Pain NOS"-tx-24-"pain"-noun-0,"Pain NOS"-tx-16-"Pain"-noun-0,"Pain NOS"-tx-4-"Pain"-noun-0]|TX|5549/4;5261/4;5214/4;4167/4;3462/4;661/4|
00000000|MMI|20.99|Cerebroside-Sulfatase|C0007804|[aapp,enzy]|["ASA"-tx-48-"ASA"-noun-0]|TX|4951/3|D08.811.277.352.827.070.250
00000000|MMI|20.88|Coumadin|C0699129|[orch,phsu]|["Coumadin"-tx-43-"coumadin"-noun-0]|TX|4693/8|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|20.85|Oxycodone|C0030049|[orch,phsu]|["OXYCODONE"-tx-4-"OXYCODONE"-noun-0]|TX|764/9|D03.132.577.249.562.149.575;D03.549.686.607.204.650;D03.605.497.607.204.650;D04.615.723.795.576.149.575
00000000|MMI|19.45|Codeine|C0009214|[orch,phsu]|["CODEINE"-tx-17-"codeine"-noun-0]|TX|3541/7|D03.132.577.249.562.149;D03.549.686.607.204;D03.605.497.607.204;D04.615.723.795.576.149
00000000|MMI|19.45|Docusate Sodium|C0243237|[orch,phsu]|["DOCUSATE SODIUM"-tx-4-"DOCUSATE SODIUM"-noun-0]|TX|442/15|D02.241.081.337.759.249
00000000|MMI|19.45|Enoxaparin|C0206460|[orch,phsu]|["Enoxaparine"-tx-6-"ENOXAPARIN"-noun-0]|TX|1203/10|D09.698.373.400.300.200
00000000|MMI|19.45|Paresthesia|C0030554|[dsyn]|["PARESTHESIAS"-tx-20-"paresthesias"-noun-0]|TX|3809/12|C10.597.751.791.875;C23.888.592.763.770.875
00000000|MMI|19.45|darbepoetin alfa|C0937950|[aapp,phsu]|["DARBEPOETIN ALFA"-tx-12-"DARBEPOETIN ALFA"-noun-0]|TX|2135/16|D12.776.395.240.150.500
00000000|MMI|19.03|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-8-"Instruction"-noun-0,"Instruction"-tx-4-"Instruction"-noun-0]|TX|1739/11;[526/11],[688/11]|I02.903
00000000|MMI|18.95|Lung|C0024109|[bpoc]|["LUNGS"-tx-58-"lungs"-noun-0,"LUNGS"-tx-30-"Lungs"-noun-0,"LUNG"-tx-15-"lung"-noun-0]|TX|5427/5;4322/5;3341/4|A04.411
00000000|MMI|18.83|Appointments|C0003629|[idcn]|["Appointments"-tx-58-"appointments"-noun-0,"Appointment"-tx-12-"APPOINTMENT"-noun-0]|TX|5452/12;2522/11|N04.452.095
00000000|MMI|18.83|Disease|C0012634|[dsyn]|["condition"-tx-59-"CONDITION"-noun-0,"condition"-tx-15-"Conditions"-noun-0]|TX|5589/9;2817/10|C23.550.288
00000000|MMI|18.28|Food|C0016452|[food]|["Food"-tx-4-"Food"-noun-0,"Food"-tx-4-"food"-noun-0]|TX|666/4;710/4|G07.203.300;J02.500
00000000|MMI|17.97|Colace|C0282139|[orch,phsu]|["Colace"-tx-4-"COLACE"-noun-0]|TX|433/6|D02.241.081.337.759.249
00000000|MMI|17.92|District of Columbia|C0012764|[geoa]|["D.C."-tx-2-"D/C"-noun-0]|TX|200/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|17.45|Interaction|C1704675|[ftcn]|["Interaction"-tx-12-"INTERACTION"-noun-0,"Interaction"-tx-8-"INTERACTION"-noun-0,"Interaction"-tx-6-"INTERACTION"-noun-0,"Interaction"-tx-4-"Interaction"-noun-0]|TX|[1988/11],[2046/11];1506/11;1064/11;676/11|
00000000|MMI|16.97|Today|C0310367|[antb,orch]|["Today"-tx-19-"today"-noun-0,"Today"-tx-9-"Today"-noun-0,"Today"-tx-8-"Today"-noun-0,"Today"-tx-6-"Today"-noun-0]|TX|3661/5;1882/5;1706/5;[1289/5],[1346/5]|
00000000|MMI|16.97|Today (temporal qualifier)|C0750526|[tmco]|["Today"-tx-19-"today"-noun-0,"Today"-tx-9-"Today"-noun-0,"Today"-tx-8-"Today"-noun-0,"Today"-tx-6-"Today"-noun-0]|TX|3661/5;1882/5;1706/5;[1289/5],[1346/5]|
00000000|MMI|16.93|10%|C3842590|[fndg]|["10%"-tx-23-"10"-fraction-1,"10%"-tx-8-"10"-integer-0,"10%"-tx-6-"10"-integer-0,"10%"-tx-4-"10"-integer-0]|TX|4044/2;1627/2;1169/2;[595/2],[815/2]|
00000000|MMI|16.85|Daily|C0332173|[tmco]|["QD"-tx-12-"QD"-noun-0,"QD"-tx-9-"QD"-noun-0,"QD"-tx-8-"QD"-noun-0,"QD"-tx-4-"QD"-noun-0]|TX|2410/2;1834/2;1694/2;[384/2],[924/2]|
00000000|MMI|16.69|Beginning|C0439659|[tmco]|["Start"-tx-58-"starting"-adj-0,"Start"-tx-9-"Starting"-adj-0,"Start"-tx-8-"Starting"-adj-0,"Start"-tx-6-"Starting"-adj-0]|TX|5389/8;1873/8;1697/8;[1280/8],[1337/8]|
00000000|MMI|16.52|Chest Pain|C0008031|[sosy]|["CHEST PAIN"-tx-22-"chest pain"-noun-1]|TX|3943/10|C10.597.617.192;C23.888.592.612.233
00000000|MMI|16.52|Electrocardiogram|C0013798|[fndg]|["EKG"-tx-39-"EKG"-noun-0]|TX|4491/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|16.52|Electrocardiography|C1623258|[diap]|["EKG"-tx-39-"EKG"-noun-0]|TX|4491/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|16.52|Glipizide|C0017642|[orch,phsu]|["GLIPIZIDE"-tx-51-"glipizide"-noun-0]|TX|5073/9|D02.886.590.795.500
00000000|MMI|16.52|Mediastinum|C0025066|[blor]|["MEDIASTINUM"-tx-15-"mediastinum"-noun-0]|TX|3352/11|A01.923.761.800.500
00000000|MMI|16.52|Milk (body substance)|C0026131|[bdsu]|["MILK"-tx-4-"milk"-noun-0]|TX|544/4|A12.200.455;G07.203.100.700;G07.203.300.350.525;J02.200.700;J02.500.350.525
00000000|MMI|16.52|Myelofibrosis|C0026987|[neop]|["MMM"-tx-25-"MMM"-noun-0]|TX|4215/3|C15.378.190.636.765
00000000|MMI|16.52|Pulse Rate|C0232117|[clna]|["PULSE"-tx-37-"Pulses"-verb-0]|TX|4437/6|E01.370.600.875.500;G09.330.380.500
00000000|MMI|16.52|Pulse taking|C0034107|[hlca]|["Pulses"-tx-37-"Pulses"-verb-0]|TX|4437/6|E01.370.370.380.650;E01.370.600.650;G09.330.380.750
00000000|MMI|16.52|Respiratory rate|C0231832|[clna]|["RESP"-tx-50-"RESP"-noun-0]|TX|4990/4|E01.370.600.875.875;G09.772.770.755.730
00000000|MMI|16.52|Trazodone|C0040805|[orch,phsu]|["TRAZODONE"-tx-55-"trazodone"-noun-0]|TX|5249/9|D03.383.606.900;D03.383.725.791.900
00000000|MMI|15.20|Chronic pain|C0150055|[sosy]|["Chronic Pain"-tx-20-"chronic pain"-noun-0]|TX|3775/7,3800/4|C10.597.617.196;C23.888.592.612.274
00000000|MMI|15.17|Fat-Restricted Diet|C0242970|[topp]|["Low fat diet, NOS"-tx-12-"Low fat DIET"-noun-0]|TX|2427/3,2446/8|E02.642.249.260;G07.203.650.240.260
00000000|MMI|15.08|Diabetes Mellitus, Insulin-Dependent|C0011854|[dsyn]|["IDDM"-tx-15-"iddm"-noun-0]|TX|2884/4|C18.452.394.750.124;C19.246.267;C20.111.327
00000000|MMI|15.08|Lesotho|C0023376|[geoa]|["LT"-tx-4-"lt"-noun-0]|TX|812/2|Z01.058.290.175.400
00000000|MMI|15.01|Clotrimazole|C0009074|[orch,phsu]|["CLOT"-tx-58-"clot"-noun-0]|TX|5414/4|D03.383.129.308.175
00000000|MMI|15.01|Drowsiness|C0013144|[fndg]|["DROWSY"-tx-24-"drowsy"-adj-0]|TX|4156/6|F02.830.855.796;G11.561.600.815.754
00000000|MMI|14.94|Saint Lucia|C0036056|[geoa]|["ST"-tx-40-"ST"-adj-0]|TX|4528/2|Z01.107.084.900.825;Z01.639.880.825
00000000|MMI|14.91|Antacids|C0003138|[phsu]|["Antacid"-tx-4-"antacid"-noun-0]|TX|553/7|D27.505.519.170;D27.505.954.483.080
00000000|MMI|14.91|Anti-Ulcer Agent|C0003216|[phsu]|["Antacid"-tx-4-"antacid"-noun-0]|TX|553/7|D27.505.954.483.203
00000000|MMI|14.90|Tylenol|C0699142|[orch,phsu]|["Tylenol"-tx-17-"Tylenol"-noun-0]|TX|3529/7|D02.065.199.092.040
00000000|MMI|14.89|Bone structure of rib|C0035561|[bpoc]|["RIBS"-tx-15-"ribs"-noun-0]|TX|3396/4|A02.835.232.904.567
00000000|MMI|14.89|Hemoglobin|C0019046|[aapp,bacs]|["Hgb"-tx-12-"Hgb"-noun-0]|TX|2244/3|D12.776.124.400;D12.776.422.316.762
00000000|MMI|14.88|isoniazid|C0022209|[orch,phsu]|["ISONIAZID"-tx-4-"INH"-noun-0]|TX|412/3|D02.442.436;D03.066.349.410;D03.383.725.394.582
00000000|MMI|14.81|Piezo-Electric Current Therapy|C1519081|[topp]|["PECT"-tx-41-"PECT"-noun-0,"PECT"-tx-20-"PECT"-noun-0,"PECT"-tx-19-"PECT"-noun-0,"PECT"-tx-18-"PECT"-noun-0]|TX|4545/4;3828/4;3669/4;3551/4|
00000000|MMI|14.63|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-14-"Dr"-noun-0,"DR"-tx-13-"Dr"-noun-0,"DR"-tx-12-"Dr"-noun-0]|TX|2608/2;2558/2;2540/2|
00000000|MMI|14.63|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-14-"Dr"-noun-0,"DR"-tx-13-"Dr"-noun-0,"DR"-tx-12-"Dr"-noun-0]|TX|2608/2;2558/2;2540/2|
00000000|MMI|14.63|Doctor - Title|C2348314|[cnce]|["Dr."-tx-14-"Dr"-noun-0,"Dr."-tx-13-"Dr"-noun-0,"Dr."-tx-12-"Dr"-noun-0]|TX|2608/2;2558/2;2540/2|
00000000|MMI|14.63|Schedule (document type)|C0086960|[inpr]|["Scheduled"-tx-58-"scheduled"-verb-0,"Scheduled"-tx-15-"scheduled"-verb-0,"Scheduled"-tx-14-"scheduled"-verb-0]|TX|5468/9;2642/9;2596/9|
00000000|MMI|14.63|Scheduled - priority|C1571999|[qlco]|["Scheduled"-tx-58-"scheduled"-verb-0,"Scheduled"-tx-15-"scheduled"-verb-0,"Scheduled"-tx-14-"scheduled"-verb-0]|TX|5468/9;2642/9;2596/9|
00000000|MMI|14.63|Scheduled - procedure status|C0205539|[qlco]|["Scheduled"-tx-58-"scheduled"-verb-0,"Scheduled"-tx-15-"scheduled"-verb-0,"Scheduled"-tx-14-"scheduled"-verb-0]|TX|5468/9;2642/9;2596/9|
00000000|MMI|13.74|Instruction [Publication Type]|C0302828|[inpr]|["Instruction"-tx-8-"Instruction"-noun-0,"Instruction"-tx-4-"Instruction"-noun-0,"instructions"-tx-4-"Instructions"-noun-0]|TX|1739/11;[526/11],[688/11];818/12|
00000000|MMI|13.74|Instructions|C1442085|[idcn]|["instruction"-tx-8-"Instruction"-noun-0,"Instructions"-tx-4-"Instructions"-noun-0,"instruction"-tx-4-"Instruction"-noun-0]|TX|1739/11;818/12;[526/11],[688/11]|
00000000|MMI|13.60|Chest|C0817096|[blor]|["CHEST"-tx-30-"CHEST"-noun-0]|TX|4314/5|A01.923.761;A02.835.232.904
00000000|MMI|13.60|Cholecystectomy procedure|C0008320|[topp]|["CHOLECYSTECTOMY"-tx-15-"cholecystectomy"-noun-0]|TX|3066/15|E04.210.120.172
00000000|MMI|13.60|Consultation|C0009818|[hlca]|["consulted"-tx-53-"consulted"-verb-0]|TX|5156/9|N04.452.758.849
00000000|MMI|13.60|Diabetes Mellitus|C0011849|[dsyn]|["DIABETES MELLITUS"-tx-15-"diabetes mellitus"-noun-0]|TX|2891/17|C18.452.394.750;C19.246
00000000|MMI|13.60|Endometriosis|C0014175|[dsyn]|["Endo"-tx-51-"ENDO"-adj-0]|TX|5047/4|C13.351.500.163
00000000|MMI|13.60|Prochlorperazine|C0033229|[orch,phsu]|["PROCHLORPERAZINE"-tx-6-"PROCHLORPERAZINE"-noun-0]|TX|1150/16|D02.886.369.639;D03.494.741.639
00000000|MMI|13.60|rosiglitazone|C0289313|[orch,phsu]|["ROSIGLITAZONE"-tx-9-"ROSIGLITAZONE"-noun-0]|TX|1810/13|x.x.x.x
00000000|MMI|13.60|ziprasidone|C0380393|[orch,phsu]|["ZIPRASIDONE"-tx-9-"ZIPRASIDONE"-noun-0]|TX|1846/11|x.x.x.x
00000000|MMI|13.57|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-12-"Reason"-noun-0,"Reason"-tx-8-"Reason"-noun-0,"Reason"-tx-6-"Reason"-noun-0]|TX|[2101/6],[2173/6];1561/6;1114/6|
00000000|MMI|13.51|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-62-"DISCHARGE"-noun-0,"Discharge"-tx-59-"DISCHARGE"-noun-0,"Discharge"-tx-15-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5773/9;5579/9;2713/9;38/9|
00000000|MMI|13.51|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-62-"DISCHARGE"-noun-0,"Discharge"-tx-59-"DISCHARGE"-noun-0,"Discharge"-tx-15-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5773/9;5579/9;2713/9;38/9|
00000000|MMI|13.47|Master of Science|C1513009|[inpr]|["M.S."-tx-61-"M."-noun-0,"M.S."-tx-11-"M."-noun-0,"M.S."-tx-8-"M."-noun-0,"M.S."-tx-6-"M."-noun-0]|TX|5723/1,5724/1;1973/1,1974/1;1448/1,1449/1;1006/1,1007/1|
00000000|MMI|13.47|m/s|C0439493|[qnco]|["m/s"-tx-61-"M."-noun-0,"m/s"-tx-11-"M."-noun-0,"m/s"-tx-8-"M."-noun-0,"m/s"-tx-6-"M."-noun-0]|TX|5723/1,5724/1;1973/1,1974/1;1448/1,1449/1;1006/1,1007/1|
00000000|MMI|13.40|Geodon|C0939698|[orch,phsu]|["Geodon"-tx-55-"geodon"-noun-0,"Geodon"-tx-9-"GEODON"-noun-0,"Geodon"-tx-8-"GEODON"-noun-0,"Geodon"-tx-6-"GEODON"-noun-0]|TX|5225/6;1837/6;1468/6;1026/6|
00000000|MMI|13.30|Serious|C0205404|[qlco]|["Serious"-tx-12-"SERIOUS"-adj-0,"Serious"-tx-8-"SERIOUS"-adj-0,"Serious"-tx-6-"SERIOUS"-adj-0]|TX|[1980/7],[2038/7];1498/7;1056/7|
00000000|MMI|13.28|Primary|C0205225|[qlco]|["Primary"-tx-56-"primary"-adj-0,"Primary"-tx-47-"primary"-adj-0,"Primary"-tx-18-"primary"-adj-0,"Principal"-tx-15-"PRINCIPAL"-adj-0]|TX|5278/7;4833/7;3630/7;2703/9|
00000000|MMI|13.28|ziprasidone hydrochloride|C0380392|[orch,phsu]|["ziprasidone hcl"-tx-12-"ZIPRASIDONE HCL"-noun-0,"ziprasidone hcl"-tx-8-"ZIPRASIDONE HCL"-noun-0,"ziprasidone hcl"-tx-6-"ZIPRASIDONE HCL"-noun-0]|TX|[2022/15],[2085/15];1545/15;1098/15|
00000000|MMI|13.22|Administration procedure|C1533734|[topp]|["Treatment"-tx-58-"treatment"-noun-0,"Treatment"-tx-57-"Treatment"-noun-0,"Treatment"-tx-15-"Treatment"-noun-0,"Treatment"-tx-12-"Treatment"-noun-0]|TX|5398/9;5306/9;2869/9;2347/9|
00000000|MMI|13.22|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-58-"treatment"-noun-0,"Treatment"-tx-57-"Treatment"-noun-0,"Treatment"-tx-15-"Treatment"-noun-0,"Treatment"-tx-12-"Treatment"-noun-0]|TX|5398/9;5306/9;2869/9;2347/9|
00000000|MMI|13.22|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-58-"treatment"-noun-0,"Treatment"-tx-57-"Treatment"-noun-0,"Treatment"-tx-15-"Treatment"-noun-0,"Treatment"-tx-12-"Treatment"-noun-0]|TX|5398/9;5306/9;2869/9;2347/9|E02
00000000|MMI|13.22|Treating|C1522326|[ftcn]|["Treatment"-tx-58-"treatment"-noun-0,"Treatment"-tx-57-"Treatment"-noun-0,"Treatment"-tx-15-"Treatment"-noun-0,"Treatment"-tx-12-"Treatment"-noun-0]|TX|5398/9;5306/9;2869/9;2347/9|
00000000|MMI|13.22|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-58-"treatment"-noun-0,"TREATMENT"-tx-57-"Treatment"-noun-0,"TREATMENT"-tx-15-"Treatment"-noun-0,"TREATMENT"-tx-12-"Treatment"-noun-0]|TX|5398/9;5306/9;2869/9;2347/9|
00000000|MMI|13.22|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-58-"treatment"-noun-0,"treatment"-tx-57-"Treatment"-noun-0,"treatment"-tx-15-"Treatment"-noun-0,"treatment"-tx-12-"Treatment"-noun-0]|TX|5398/9;5306/9;2869/9;2347/9|
00000000|MMI|13.15|June|C3829443|[tmco]|["June"-tx-9-"June"-noun-0,"June"-tx-8-"June"-noun-0,"June"-tx-6-"June"-noun-0]|TX|1888/4;1712/4;[1295/4],[1352/4]|
00000000|MMI|12.27|Heart Sounds|C0018820|[ortf]|["HEART SOUNDS"-tx-28-"heart sounds"-noun-0]|TX|4282/12|G09.330.380.510
00000000|MMI|12.26|BM-06|C3501305|[bacs,nnon]|["BM-06"-tx-23-"BM 06"-noun-0]|TX|4035/2,4050/2|x.x.x.x
00000000|MMI|12.20|Compazine|C0701017|[orch,phsu]|["Compazine"-tx-6-"COMPAZINE"-noun-0]|TX|1138/9|D02.886.369.639;D03.494.741.639
00000000|MMI|12.16|Nutritional status|C0392209|[fndg]|["nutrition"-tx-53-"nutrition"-noun-0]|TX|5146/9|G07.203.650.650;N01.224.425.525
00000000|MMI|12.16|Solomon Islands|C0037623|[geoa]|["BP"-tx-24-"BP"-noun-0]|TX|4092/2|Z01.639.760.590
00000000|MMI|12.14|DSP protein, human|C1531217|[aapp,bacs]|["DP"-tx-37-"DP"-noun-0]|TX|4452/2|x.x.x.x
00000000|MMI|12.14|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-59-"PLAN"-noun-0]|TX|5613/4|C10.228.140.744
00000000|MMI|12.14|Leg|C1140621|[blor]|["LEG"-tx-20-"leg"-noun-0]|TX|3796/3|A01.378.610.500
00000000|MMI|12.13|Diet|C0012155|[food]|["Diet"-tx-12-"DIET"-noun-0]|TX|2413/4|G07.203.650.240
00000000|MMI|12.13|Tristetraprolin|C0084795|[aapp,bacs]|["TTP"-tx-31-"TTP"-noun-0]|TX|4356/3|D12.776.260.790;D12.776.460.762;D12.776.930.960
00000000|MMI|12.12|Movement|C0026649|[orgf]|["Movement"-tx-16-"movement"-noun-0]|TX|3497/8|G07.700.560;G11.427.590.530
00000000|MMI|12.09|Embolus|C1704212|[fndg]|["EMBOLUS"-tx-19-"embolus"-noun-0]|TX|3741/7|C14.907.355.350
00000000|MMI|12.07|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-2-"D/C"-noun-0]|TX|200/3|E04.157.310;E04.950.300.299
00000000|MMI|12.03|Lifting|C0206244|[acty]|["Lifting"-tx-15-"lifting"-adj-0]|TX|3444/7|G01.374.676.530;G01.595.540.530
00000000|MMI|12.01|Dietary Iron|C0376520|[inch]|["Iron"-tx-44-"iron"-noun-0]|TX|4752/4|D01.490.600;D02.691.550.600
00000000|MMI|12.01|Iron|C0302583|[bacs,elii,phsu]|["IRON"-tx-44-"iron"-noun-0]|TX|4752/4|D01.268.556.412;D01.268.956.287;D01.552.544.412;x.x.x.x
00000000|MMI|12.01|Oxygen|C0030054|[elii,phsu]|["O2"-tx-24-"O2"-noun-0]|TX|4111/2|D01.268.185.550;D01.362.670;x.x.x.x
00000000|MMI|12.01|Rehabilitation therapy|C0034991|[topp]|["Rehabilitation"-tx-4-"Rehabilitation"-noun-0]|TX|316/14|E02.831;H02.403.680.600;N02.421.784
00000000|MMI|12.01|Taiwan|C0039260|[geoa]|["TW"-tx-40-"TW"-noun-0]|TX|4531/2|Z01.252.474.872;Z01.639.850
00000000|MMI|12.00|PO-2|C0297199|[orch]|["PO-2"-tx-4-"PO 2"-noun-0]|TX|381/2,405/1|x.x.x.x
00000000|MMI|12.00|Kyrgyzstan|C0022718|[geoa]|["KG"-tx-24-"kg"-noun-0]|TX|4130/2|Z01.252.100.450;Z01.586.200.450;Z01.586.950.450
00000000|MMI|11.99|Nausea|C0027497|[sosy]|["NAUSEA"-tx-6-"Nausea"-noun-0]|TX|1186/6|C23.888.821.712
00000000|MMI|11.99|ferrous sulfate|C0060282|[inch,phsu]|["Ferrous sulphate"-tx-4-"FERROUS SULFATE"-noun-0]|TX|474/15|x.x.x.x
00000000|MMI|11.99|Coughing|C0010200|[sosy]|["COUGH"-tx-4-"cough"-noun-0]|TX|627/5|C08.618.248;C23.888.852.293
00000000|MMI|11.98|Wheezing|C0043144|[sosy]|["WHEEZING"-tx-4-"Wheezing"-noun-0]|TX|424/8|C23.888.852.779;E01.370.386.720;G09.772.775
00000000|MMI|11.98|4-azido-7-phenylpyrazolo-(1,5a)-1,3,5-triazine|C0245203|[bacs,orch]|["APPT"-tx-59-"appts"-noun-0]|TX|5641/5|x.x.x.x
00000000|MMI|11.96|Neoplasm Metastasis|C0027627|[neop]|["Metastasis"-tx-15-"metastasis"-noun-0]|TX|3275/10|C04.697.650;C23.550.727.650
00000000|MMI|11.04|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-15-"DIAGNOSIS"-noun-0,"DIAGNOSIS"-tx-12-"Diagnosis"-noun-0]|TX|[2673/9],[2807/9];2300/9|E01
00000000|MMI|11.04|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-15-"DIAGNOSIS"-noun-0,"DIAGNOSIS"-tx-12-"Diagnosis"-noun-0]|TX|[2673/9],[2807/9];2300/9|
00000000|MMI|10.67|Abdomen|C0000726|[blor]|["abd"-tx-32-"ABD"-noun-0]|TX|4362/3|A01.923.047
00000000|MMI|10.67|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-15-"ALLERGY"-noun-0]|TX|2654/7|H02.403.044
00000000|MMI|10.67|Anemia|C0002871|[dsyn]|["ANEMIA"-tx-12-"Anemia"-noun-0]|TX|2226/6|C15.378.071
00000000|MMI|10.67|Bone Tissue|C0391978|[tisu]|["BONE"-tx-15-"bone"-noun-0]|TX|3334/4|A02.835.232;A10.165.265
00000000|MMI|10.67|Brain|C0006104|[bpoc]|["BRAIN"-tx-15-"brain"-noun-0]|TX|3289/5|A08.186.211
00000000|MMI|10.67|Complication Aspects|C1171258|[patf]|["complications"-tx-15-"Complications"-noun-0]|TX|2843/13|x.x.x
00000000|MMI|10.67|Ischemia|C0022116|[patf]|["Ischaemia, NOS"-tx-48-"ISCHEMIA"-noun-0]|TX|4916/8|C23.550.513
00000000|MMI|10.67|Methods aspects|C0025664|[inpr]|["procedures"-tx-15-"PROCEDURES"-noun-0]|TX|3122/10|x.x.x
00000000|MMI|10.67|Physical Examination|C0031809|[hlca]|["PHYSICAL EXAM"-tx-24-"PHYSICAL EXAM"-noun-0]|TX|4056/13|E01.370.600
00000000|MMI|10.58|Asthma Pathway|C2984299|[ftcn]|["Asthma"-tx-50-"Asthma"-noun-0,"Asthma"-tx-15-"asthma"-noun-0]|TX|4996/6;[2984/6],[2993/6]|
00000000|MMI|10.09|Constipation Adverse Event|C1963087|[fndg]|["Constipation"-tx-54-"constipation"-noun-0,"Constipation"-tx-23-"constipation"-noun-0,"Constipation"-tx-4-"Constipation"-noun-0]|TX|5191/12;4006/12;751/12|
00000000|MMI|10.04|Additional|C1524062|[ftcn]|["Added"-tx-9-"added"-verb-0,"Added"-tx-6-"added"-verb-0,"Added"-tx-4-"added"-verb-0]|TX|1920/5;1395/5;953/5|
00000000|MMI|9.87|Primary operation|C0439631|[topp]|["Primary"-tx-56-"primary"-adj-0,"Primary"-tx-47-"primary"-adj-0,"Primary"-tx-18-"primary"-adj-0]|TX|5278/7;4833/7;3630/7|
00000000|MMI|9.87|True primary (qualifier value)|C0439612|[tmco]|["Primary"-tx-56-"primary"-adj-0,"Primary"-tx-47-"primary"-adj-0,"Primary"-tx-18-"primary"-adj-0]|TX|5278/7;4833/7;3630/7|
00000000|MMI|9.81|/hour|C0564385|[qnco]|["/h"-tx-9-"H"-noun-0,"/h"-tx-6-"H"-noun-0,"/h"-tx-4-"H"-noun-0]|TX|1959/1;1434/1;992/1|
00000000|MMI|9.81|H NOS Antibodies|C0369286|[aapp,imft]|["H NOS"-tx-9-"H"-noun-0,"H NOS"-tx-6-"H"-noun-0,"H NOS"-tx-4-"H"-noun-0]|TX|1959/1;1434/1;992/1|
00000000|MMI|9.81|Hepatic Involvement|C0441932|[clas]|["H+"-tx-9-"H"-noun-0,"H+"-tx-6-"H"-noun-0,"H+"-tx-4-"H"-noun-0]|TX|1959/1;1434/1;992/1|
00000000|MMI|9.74|Three times daily|C0556984|[tmco]|["TID"-tx-6-"TID"-noun-0,"TID"-tx-4-"TID"-noun-0]|TX|1333/3;[500/3],[653/3]|
00000000|MMI|9.74|three times a day at institution-specified times|C1610169|[tmco]|["TID"-tx-6-"TID"-noun-0,"TID"-tx-4-"TID"-noun-0]|TX|1333/3;[500/3],[653/3]|
00000000|MMI|9.67|Cardiovascular System Findings Domain|C3538987|[idcn]|["CV"-tx-48-"CV"-noun-0,"CV"-tx-28-"CV"-noun-0]|TX|4912/2;4270/2|
00000000|MMI|9.67|Obesity Adverse Event|C1963185|[fndg]|["Obesity"-tx-15-"obesity"-noun-0]|TX|[3030/7],[3040/7]|
00000000|MMI|9.67|Retained|C0333118|[ftcn]|["Keep"-tx-59-"keep"-verb-0,"Keep"-tx-58-"keep"-verb-0]|TX|5632/4;5442/4|
00000000|MMI|9.67|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-62-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|5783/6;48/6|
00000000|MMI|9.40|Pleurisy|C0032231|[dsyn]|["Pleuritides"-tx-16-"pleuritic"-adj-0]|TX|3470/9|C08.528.735;C08.730.582
00000000|MMI|9.27|pharmacotherapeutic|C0013217|[ftcn]|["chemotherapy"-tx-12-"Chemotherapy"-noun-0]|TX|2205/12|x.x.x
00000000|MMI|9.23|Back|C0004600|[blor]|["BACK"-tx-21-"back"-noun-0]|TX|3881/4|A01.923.176
00000000|MMI|9.21|Lower Extremity|C0023216|[blor]|["Leg"-tx-20-"leg"-noun-0]|TX|3796/3|A01.378.610
00000000|MMI|9.20|Diet therapy|C0012159|[hlca]|["Diet"-tx-12-"DIET"-noun-0]|TX|2413/4|E02.642.249
00000000|MMI|9.19|Anxiety|C0003467|[mobd]|["-- Anxiety"-tx-6-"Anxiety"-noun-0]|TX|1361/7|F01.470.132
00000000|MMI|9.08|Rehabilitation aspects|C0034992|[ftcn]|["Rehabilitation"-tx-4-"Rehabilitation"-noun-0]|TX|316/14|x.x.x
00000000|MMI|9.07|metastatic qualifier|C1522484|[qnco]|["metastatic"-tx-15-"metastatic"-adj-0]|TX|3086/10|x.x.x
00000000|MMI|9.04|Intestines|C0021853|[bpoc]|["Bowel"-tx-54-"bowel"-noun-0]|TX|5173/5|A03.556.124
00000000|MMI|7.74|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-15-"ALLERGY"-noun-0]|TX|2654/7|C20.543
00000000|MMI|7.74|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-15-"ALLERGY"-noun-0]|TX|2654/7|C20.543
00000000|MMI|7.74|Infection|C3714514|[patf]|["Infections"-tx-15-"Infections"-noun-0]|TX|2830/10|C01.539
00000000|MMI|7.74|Neck|C0027530|[blor]|["NECK"-tx-26-"NECK"-noun-0]|TX|4229/4|A01.598
00000000|MMI|7.68|Call (Instruction)|C1947967|[ftcn]|["Call"-tx-58-"call"-verb-0,"Call"-tx-21-"called"-verb-0]|TX|5487/4;3866/6|
00000000|MMI|7.68|Decision|C0679006|[menp]|["Call"-tx-58-"call"-verb-0,"Call"-tx-21-"called"-verb-0]|TX|5487/4;3866/6|
00000000|MMI|7.14|Hospital admission|C0184666|[hlca]|["Admission"-tx-15-"Admission"-noun-0,"Admit"-tx-15-"ADMIT"-verb-0]|TX|2770/9;2667/5|
00000000|MMI|7.06|Avandia|C0875967|[orch,phsu]|["Avandia"-tx-51-"avandia"-noun-0,"Avandia"-tx-9-"AVANDIA"-noun-0]|TX|5063/7;1800/7|
00000000|MMI|7.06|Condition|C0348080|[qlco]|["Condition"-tx-59-"CONDITION"-noun-0,"Condition"-tx-15-"Conditions"-noun-0]|TX|5589/9;2817/10|
00000000|MMI|7.06|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-59-"CONDITION"-noun-0,"Condition"-tx-15-"Conditions"-noun-0]|TX|5589/9;2817/10|
00000000|MMI|7.06|Logical Condition|C1705253|[cnce]|["Condition"-tx-59-"CONDITION"-noun-0,"Condition"-tx-15-"Conditions"-noun-0]|TX|5589/9;2817/10|
00000000|MMI|6.98|Reading (datum presentation)|C1705179|[fndg]|["read"-tx-19-"read"-verb-0,"read"-tx-18-"read"-verb-0]|TX|3678/4;3566/4|
00000000|MMI|6.95|Carcinoma breast stage IV|C0278488|[neop]|["Metastatic Breast Cancer"-tx-46-"Metastatic breast cancer"-noun-0,"Metastatic Breast Cancer"-tx-15-"metastatic breast cancer"-noun-0]|TX|4792/24;3245/24|
00000000|MMI|6.94|Current (present time)|C0521116|[tmco]|["Currently"-tx-21-"currently"-adv-0,"Currently"-tx-15-"currently"-adv-0]|TX|3895/9;3295/9|
00000000|MMI|6.94|Negation|C1518422|[ftcn]|["Not"-tx-23-"not"-adv-0,"Not"-tx-15-"NOT"-adv-0]|TX|4027/3;3169/3|
00000000|MMI|6.89|Entire brain|C1269537|[bpoc]|["Brain"-tx-15-"brain"-noun-0,"Whole brain"-tx-15-"whole-brain"-noun-0]|TX|3289/5;3316/11|
00000000|MMI|6.87|ALYREF gene|C1425988|[gngm]|["REF"-tx-8-"ref"-noun-0,"REF"-tx-6-"ref"-noun-0]|TX|1480/3;1038/3|
00000000|MMI|6.82|Gram per Deciliter|C0439267|[qnco]|["g%"-tx-29-"g"-noun-0,"g%"-tx-2-"G"-noun-0]|TX|4310/1;270/1|
00000000|MMI|6.79|10 - 19|C3843800|[fndg]|["10 - 19"-tx-62-"10/19"-fraction-0,"10 - 19"-tx-2-"10/19"-fraction-0]|TX|5739/5;143/5|
00000000|MMI|6.78|Hypercholesterolemia result|C1522133|[fndg]|["Hypercholesterolemia"-tx-52-"Hypercholesterolemia"-noun-0,"Hypercholesterolemia"-tx-15-"hypercholesterolemia"-noun-0]|TX|5085/20;2913/20|
00000000|MMI|6.78|To|C1883351|[qlco]|["To"-tx-26-"to"-adv-0,"To"-tx-21-"to"-adv-0]|TX|4249/2;3873/2|
00000000|MMI|6.74|Hospital course|C0489547|[fndg]|["Hospital course"-tx-42-"HOSPITAL COURSE"-noun-0,"Hospital course"-tx-15-"HOSPITAL COURSE"-noun-1]|TX|4573/15;3204/15|
00000000|MMI|6.74|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-42-"HOSPITAL COURSE"-noun-0,"Hospital course"-tx-15-"HOSPITAL COURSE"-noun-0]|TX|4573/15;3204/15|
00000000|MMI|6.73|Summary (document)|C1706244|[inpr]|["Summary"-tx-59-"summary"-noun-0,"Summary"-tx-2-"SUMMARY"-noun-0]|TX|5676/7;229/7|
00000000|MMI|6.73|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-59-"summary"-noun-0,"summary"-tx-2-"SUMMARY"-noun-0]|TX|5676/7;229/7|
00000000|MMI|6.67|Negative - answer|C3853545|[qlco]|["NEG"-tx-20-"neg"-adj-0,"Negative"-tx-18-"negative"-noun-0]|TX|3837/3;3574/8|
00000000|MMI|6.64|Regimen - CHV concept|C2945654|[inpr]|["regimen"-tx-56-"regimen"-noun-0,"regimen"-tx-54-"regimen"-noun-0]|TX|5266/7;5179/7|
00000000|MMI|6.59|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-62-"PM"-noun-0,"PM"-tx-2-"PM"-adj-0]|TX|5756/2;161/2|
00000000|MMI|6.59|Neoplasms|C0027651|[neop]|["Oncology"-tx-47-"oncology"-noun-0,"Oncology"-tx-12-"Oncology"-noun-0]|TX|4841/8;2194/8|C04
00000000|MMI|6.59|oncology field|C0278627|[bmod]|["Oncology"-tx-47-"oncology"-noun-0,"Oncology"-tx-12-"Oncology"-noun-0]|TX|4841/8;2194/8|
00000000|MMI|6.58|oncologist|C0259990|[prog]|["ONCOLOGIST"-tx-56-"oncologist"-noun-0,"ONCOLOGIST"-tx-18-"oncologist"-noun-0]|TX|5286/10;3638/10|
00000000|MMI|6.58|80%|C3842583|[fndg]|["80%"-tx-24-"80"-fraction-0,"80%"-tx-9-"80"-integer-0]|TX|4099/2;1860/2|
00000000|MMI|6.57|P Blood group antibodies|C0369773|[aapp,imft]|["P NOS"-tx-24-"P"-noun-0,"P NOS"-tx-15-"p"-adj-0]|TX|4085/1;3403/1|
00000000|MMI|6.57|P prime|C2603361|[clna]|["P'"-tx-24-"P"-noun-0,"P'"-tx-15-"p"-adj-0]|TX|4085/1;3403/1|
00000000|MMI|6.54|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-18-"follow up"-adj-0,"FOLLOW-UP"-tx-12-"FOLLOW UP"-adj-0]|TX|3617/9;2512/9|
00000000|MMI|6.54|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-18-"follow up"-adj-0,"Follow-Up"-tx-12-"FOLLOW UP"-adj-0]|TX|3617/9;2512/9|
00000000|MMI|6.54|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-18-"follow up"-adj-0,"Follow-up"-tx-12-"FOLLOW UP"-adj-0]|TX|3617/9;2512/9|
00000000|MMI|6.54|follow-up|C1522577|[hlca]|["Follow Up"-tx-18-"follow up"-adj-0,"Follow Up"-tx-12-"FOLLOW UP"-adj-0]|TX|3617/9;2512/9|
00000000|MMI|6.54|Home environment|C0442519|[cnce]|["HOME"-tx-18-"home"-noun-0,"house"-tx-12-"House"-noun-0]|TX|3607/4;2419/5|
00000000|MMI|6.54|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose #"-tx-57-"dose"-noun-0,"Dose number"-tx-8-"Number Doses"-noun-0]|TX|5316/4;1585/6,1595/5|
00000000|MMI|6.51|30%|C3842588|[fndg]|["30%"-tx-8-"30"-integer-0,"30%"-tx-4-"30"-integer-0]|TX|1685/2;725/2|
00000000|MMI|6.51|Code|C0805701|[inpr]|["CODE"-tx-4-"CODE"-noun-0,"CODE"-tx-4-"code"-noun-0]|TX|280/4;298/4|
00000000|MMI|6.51|Every four hours|C0585324|[tmco]|["Q4H"-tx-4-"Q4H"-noun-0]|TX|[613/3],[782/3]|
00000000|MMI|6.51|Food allergenic extracts|C3540798|[imft,phsu]|["food"-tx-4-"Food"-noun-0,"food"-tx-4-"food"-noun-0]|TX|666/4;710/4|
00000000|MMI|6.51|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-4-"CODE"-noun-0,"Code"-tx-4-"code"-noun-0]|TX|280/4;298/4|
00000000|MMI|6.51|milliliter|C0439242|[qnco]|["MILLILITER"-tx-4-"MILLILITERS"-noun-0]|TX|[598/11],[728/11]|
00000000|MMI|6.51|Four times daily|C0585291|[tmco]|["QID"-tx-4-"QID"-adv-0]|TX|[416/3],[743/3]|
00000000|MMI|6.45|100%|C3817553|[qnco]|["100%"-tx-24-"100"-integer-0,"100%"-tx-4-"100"-integer-0]|TX|4126/3;460/3|
00000000|MMI|6.40|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-58-"ED"-noun-0,"ED"-tx-15-"ED"-noun-0]|TX|5517/2;3410/2|
00000000|MMI|6.34|Chemotherapy|C3665472|[topp]|["Chemotherapy"-tx-12-"Chemotherapy"-noun-0]|TX|2205/12|E02.319
00000000|MMI|6.34|Pharmacotherapy|C0013216|[topp]|["Chemotherapy"-tx-12-"Chemotherapy"-noun-0]|TX|2205/12|E02.319
00000000|MMI|6.32|Physical therapy|C0949766|[topp]|["Physical Therapy"-tx-59-"physical therapy"-noun-0]|TX|5647/16|E02.779
00000000|MMI|6.30|Science of nutrition|C0028707|[bmod]|["Nutrition"-tx-53-"nutrition"-noun-0]|TX|5146/9|H02.533
00000000|MMI|6.26|Anxiety Disorders|C0003469|[mobd]|["Anxiety"-tx-6-"Anxiety"-noun-0]|TX|1361/7|F03.080
00000000|MMI|6.18|Maintenance|C0024501|[acty]|["Maintenance"-tx-12-"Maintenance"-noun-0]|TX|2364/11|N02.628
00000000|MMI|6.13|Inhaler|C0021461|[medd]|["INHALER"-tx-4-"INHALER"-noun-0]|TX|397/7|E07.605
00000000|MMI|6.11|Time|C0040223|[tmco]|["TIME"-tx-12-"time"-noun-0]|TX|2257/4|G01.910
00000000|MMI|4.81|+2|C0740116|[qnco]|["+2"-tx-14-"2"-integer-0]|TX|2589/1|
00000000|MMI|4.81|2+|C3833492|[fndg]|["2+"-tx-14-"2"-integer-0]|TX|2589/1|
00000000|MMI|4.81|2+ Score|C2827735|[qnco]|["2+"-tx-14-"2"-integer-0]|TX|2589/1|
00000000|MMI|4.81|2+ Score, WHO|C2981700|[clas]|["2+"-tx-14-"2"-integer-0]|TX|2589/1|
00000000|MMI|4.81|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-15-"3"-integer-0]|TX|2635/1|
00000000|MMI|4.81|3+ Score|C2827736|[qnco]|["3+"-tx-15-"3"-integer-0]|TX|2635/1|
00000000|MMI|4.81|3+ Score, WHO|C2981702|[clas]|["3+"-tx-15-"3"-integer-0]|TX|2635/1|
00000000|MMI|4.81|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-15-"3"-integer-0]|TX|2635/1|
00000000|MMI|4.81|ABD tumor staging notation|C0449202|[inpr]|["ABD"-tx-32-"ABD"-noun-0]|TX|4362/3|
00000000|MMI|4.81|Absence of Biallelic TCRgamma Deletion|C3811055|[comd]|["ABD"-tx-32-"ABD"-noun-0]|TX|4362/3|
00000000|MMI|4.81|Additional comments|C1830770|[fndg]|["Additional comments"-tx-58-"ADDITIONAL COMMENTS"-noun-0]|TX|5337/19|
00000000|MMI|4.81|Affecting|C0392760|[ftcn]|["Affecting"-tx-15-"affecting"-verb-0]|TX|2859/9|
00000000|MMI|4.81|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-15-"ALLERGY"-noun-0]|TX|2654/7|
00000000|MMI|4.81|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-15-"ALLERGY"-noun-0]|TX|2654/7|
00000000|MMI|4.81|Anterior thoracic region|C1527391|[blor]|["Chest"-tx-30-"CHEST"-noun-0]|TX|4314/5|
00000000|MMI|4.81|Approximate|C0332232|[qlco]|["Approximate"-tx-8-"approximate"-adj-0]|TX|1612/11|
00000000|MMI|4.81|Assessed|C1516048|[acty]|["Assess"-tx-26-"assess"-verb-0]|TX|4252/6|
00000000|MMI|4.81|Biospecimen Domain|C3814390|[inpr]|["BS"-tx-33-"BS"-noun-0]|TX|4384/2|
00000000|MMI|4.81|Black Swiss Mouse|C4049076|[mamm]|["BS"-tx-33-"BS"-noun-0]|TX|4384/2|
00000000|MMI|4.81|Bug Search Subtest (WPPSI-IV)|C4050217|[inpr]|["BS"-tx-33-"BS"-noun-0]|TX|4384/2|
00000000|MMI|4.81|Chest pain:Finding:Point in time:^Patient:Ordinal|C2926613|[clna]|["Chest pain"-tx-22-"chest pain"-noun-0]|TX|3943/10|
00000000|MMI|4.81|Complication|C0009566|[patf]|["Complications"-tx-15-"Complications"-noun-0]|TX|2843/13|
00000000|MMI|4.81|Cow's milk|C0349374|[food]|["Milk"-tx-4-"milk"-noun-0]|TX|544/4|
00000000|MMI|4.81|Decreased|C0205216|[qnco]|["Decreased"-tx-33-"decreased"-verb-0]|TX|4387/9|
00000000|MMI|4.81|Decreasing|C0442797|[qlco]|["decreased"-tx-33-"decreased"-verb-0]|TX|4387/9|
00000000|MMI|4.81|Deny (action)|C2700401|[acty]|["Deny"-tx-22-"denies"-verb-0]|TX|3930/6|
00000000|MMI|4.81|Difficult (qualifier value)|C0332218|[qlco]|["Difficult"-tx-26-"difficult"-adj-0]|TX|4239/9|
00000000|MMI|4.81|Digestive System Findings Domain|C3539617|[inpr]|["GI"-tx-53-"GI"-noun-0]|TX|5125/2|
00000000|MMI|4.81|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|4.81|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|4.81|Entire bone (organ)|C1266908|[bpoc]|["Bone, NOS"-tx-15-"bone"-noun-0]|TX|3334/4|
00000000|MMI|4.81|Entire bony skeleton|C1266909|[bdsy]|["Bone"-tx-15-"bone"-noun-0]|TX|3334/4|
00000000|MMI|4.81|Entire lung|C1278908|[bpoc]|["Lung"-tx-15-"lung"-noun-0]|TX|3341/4|
00000000|MMI|4.81|Entire mediastinum|C1278909|[bpoc]|["Mediastinum"-tx-15-"mediastinum"-noun-0]|TX|3352/11|
00000000|MMI|4.81|Entire neck|C1281592|[bpoc]|["Neck"-tx-26-"NECK"-noun-0]|TX|4229/4|
00000000|MMI|4.81|Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}|C1316572|[clna]|["Note"-tx-20-"note"-noun-0]|TX|3761/4|
00000000|MMI|4.81|Extended Release Dosage Form|C1707968|[bodm]|["Extended Release"-tx-8-"EXTENDED RELEASE"-adj-0]|TX|1643/16|
00000000|MMI|4.81|Fluticasone propionate|C0117996|[orch,phsu]|["FLUTICASONE PROPIONATE"-tx-6-"FLUTICASONE PROPIONATE"-noun-0]|TX|1239/22|
00000000|MMI|4.81|GNAI1 wt Allele|C1708130|[gngm]|["Gi"-tx-53-"GI"-noun-0]|TX|5125/2|
00000000|MMI|4.81|GRAPEFRUIT EXTRACT|C0440280|[orch,phsu]|["GRAPEFRUIT"-tx-8-"grapefruit"-noun-0]|TX|1757/10|
00000000|MMI|4.81|Gastrointestinal studies and measurements|C4050121|[inpr]|["GI"-tx-53-"GI"-noun-0]|TX|5125/2|
00000000|MMI|4.81|Genus Anemia|C1000483|[plnt]|["Anemia"-tx-12-"Anemia"-noun-0]|TX|2226/6|
00000000|MMI|4.81|Grapefruit (food)|C0995150|[food]|["GRAPEFRUIT"-tx-8-"grapefruit"-noun-0]|TX|1757/10|
00000000|MMI|4.81|Grapefruit Flavor|C1365950|[food]|["GRAPEFRUIT"-tx-8-"grapefruit"-noun-0]|TX|1757/10|
00000000|MMI|4.81|HEENT|C1512338|[blor]|["HEENT"-tx-25-"HEENT"-noun-0]|TX|4200/5|
00000000|MMI|4.81|Has difficulty doing (qualifier value)|C1299586|[fndg]|["Difficult"-tx-26-"difficult"-adj-0]|TX|4239/9|
00000000|MMI|4.81|Hold (action)|C1948035|[acty]|["Hold"-tx-4-"HOLD"-verb-0]|TX|786/4|
00000000|MMI|4.81|Hold - dosing instruction fragment|C1553387|[idcn]|["Hold"-tx-4-"HOLD"-verb-0]|TX|786/4|
00000000|MMI|4.81|Hypertension Adverse Event|C1963138|[fndg]|["Hypertension"-tx-15-"hypertension"-noun-0]|TX|2967/12|
00000000|MMI|4.81|Including (qualifier)|C0332257|[ftcn]|["Including"-tx-15-"including"-verb-0]|TX|3364/9|
00000000|MMI|4.81|Induce (action)|C0205263|[ftcn]|["Induced"-tx-12-"Induced"-verb-0]|TX|2218/7|
00000000|MMI|4.81|Initially|C0205265|[tmco]|["Initially"-tx-18-"initially"-adv-0]|TX|3556/9|
00000000|MMI|4.81|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-15-"PROCEDURES"-noun-0]|TX|3122/10|
00000000|MMI|4.81|Involvement with|C1314939|[ftcn]|["Affecting"-tx-15-"affecting"-verb-0]|TX|2859/9|
00000000|MMI|4.81|Last|C1517741|[qlco]|["Last"-tx-12-"Last"-verb-0]|TX|2233/4|
00000000|MMI|4.81|MANEA gene|C1427293|[gngm]|["ENDO"-tx-51-"ENDO"-adj-0]|TX|5047/4|
00000000|MMI|4.81|Metastatic malignant neoplasm to brain|C0220650|[neop]|["Brain Metastasis"-tx-43-"brain metastasis"-noun-0]|TX|4713/16|
00000000|MMI|4.81|Milk - dietary|C2825079|[food]|["MILK"-tx-4-"milk"-noun-0]|TX|544/4|
00000000|MMI|4.81|Milk Specimen|C0444318|[sbst]|["Milk"-tx-4-"milk"-noun-0]|TX|544/4|
00000000|MMI|4.81|Murphy's sign|C0277977|[sosy]|["Murphy sign"-tx-35-"Murphy's sign"-noun-1]|TX|4409/13|
00000000|MMI|4.81|NADPH:sulfur oxidoreductase activity|C2700623|[moft]|["NSR"-tx-39-"NSR"-noun-0]|TX|4496/3|
00000000|MMI|4.81|Neutral Sidebent Rotated|C1704493|[patf]|["NSR"-tx-39-"NSR"-noun-0]|TX|4496/3|
00000000|MMI|4.81|Not Applicable|C1272460|[qlco]|["NOT APPLICABLE"-tx-2-"Not Applicable"-adj-0]|TX|180/14|
00000000|MMI|4.81|Note (document)|C1317574|[inpr]|["Note"-tx-20-"note"-noun-0]|TX|3761/4|
00000000|MMI|4.81|Orientation (spatial)|C1704322|[spco]|["Oriented"-tx-24-"oriented"-verb-0]|TX|4189/8|
00000000|MMI|4.81|Oriented to place|C1961028|[fndg]|["Oriented"-tx-24-"oriented"-verb-0]|TX|4189/8|
00000000|MMI|4.81|PPP4C gene|C1418850|[gngm]|["PPX"-tx-57-"PPX"-noun-0]|TX|5301/3|
00000000|MMI|4.81|Package Type Not Applicable|C4049872|[ftcn]|["Not Applicable"-tx-2-"Not Applicable"-adj-0]|TX|180/14|
00000000|MMI|4.81|Palpitations|C0030252|[fndg]|["PALPITATIONS"-tx-22-"palpitations"-noun-1]|TX|3956/12|
00000000|MMI|4.81|Palpitations Adverse Event|C3160712|[fndg]|["Palpitations"-tx-22-"palpitations"-noun-1]|TX|3956/12|
00000000|MMI|4.81|Physical Exam Domain|C1744699|[inpr]|["Physical Exam"-tx-24-"PHYSICAL EXAM"-noun-0]|TX|4056/13|
00000000|MMI|4.81|Physiologic pulse|C0391850|[phsf]|["Pulse"-tx-37-"Pulses"-verb-0]|TX|4437/6|
00000000|MMI|4.81|Positive|C1446409|[qlco]|["Positive"-tx-19-"positive"-noun-0]|TX|3694/8|
00000000|MMI|4.81|Positive Charge|C2825490|[qlco]|["Positive"-tx-19-"positive"-noun-0]|TX|3694/8|
00000000|MMI|4.81|Positive Finding|C1514241|[fndg]|["POSITIVE"-tx-19-"positive"-noun-0]|TX|3694/8|
00000000|MMI|4.81|Positive Number|C3812269|[cnce]|["Positive"-tx-19-"positive"-noun-0]|TX|3694/8|
00000000|MMI|4.81|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-15-"PROCEDURES"-noun-0]|TX|3122/10|
00000000|MMI|4.81|Pulse phenomenon|C1947910|[phpr]|["Pulse"-tx-37-"Pulses"-verb-0]|TX|4437/6|
00000000|MMI|4.81|Pupil equal round and reacting to light|C1642390|[fndg]|["PERRL"-tx-25-"PERRL"-noun-0]|TX|4221/5|
00000000|MMI|4.81|Reduced|C0392756|[qlco]|["Decreased"-tx-33-"decreased"-verb-0]|TX|4387/9|
00000000|MMI|4.81|Refused|C1705116|[acty]|["REFUSE"-tx-4-"refuse"-verb-0]|TX|839/6|
00000000|MMI|4.81|Requirement|C1514873|[ftcn]|["Required"-tx-8-"Required"-verb-0]|TX|1601/8|
00000000|MMI|4.81|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-15-"ALLERGY"-noun-0]|TX|2654/7|
00000000|MMI|4.81|S prime|C2603362|[clna]|["S'"-tx-12-"("-noun-0]|TX|2533/1|
00000000|MMI|4.81|Scientific Study|C0947630|[lbpr]|["studies"-tx-39-"STUDIES"-noun-0]|TX|4480/7|
00000000|MMI|4.81|Shortness of breath:-:Point in time:^Patient:-|C2707305|[clna]|["Shortness of breath"-tx-58-"shortness of breath"-noun-0]|TX|5557/19|
00000000|MMI|4.81|Skeletal bone|C0262950|[bpoc]|["BONE"-tx-15-"bone"-noun-0]|TX|3334/4|
00000000|MMI|4.81|Structure of parenchyma of lung|C0819757|[tisu]|["LUNG"-tx-15-"lung"-noun-0]|TX|3341/4|
00000000|MMI|4.81|Structure of right lower lobe of lung|C1261075|[bpoc]|["RLL"-tx-19-"RLL"-noun-0]|TX|3752/3|
00000000|MMI|4.81|TAC1 wt Allele|C1705924|[gngm]|["NKA"-tx-15-"NKA"-noun-0]|TX|2663/3|
00000000|MMI|4.81|Warmer, device|C0184348|[medd]|["Warm"-tx-36-"Warm"-adj-0]|TX|4430/4|
00000000|MMI|4.81|Zometa|C0939788|[orch,phsu]|["Zometa"-tx-47-"zometa"-noun-0]|TX|4890/6|
00000000|MMI|4.81|atorvastatin|C0286651|[orch,phsu]|["ATORVASTATIN"-tx-12-"ATORVASTATIN"-noun-0]|TX|2386/12|
00000000|MMI|4.81|dendritic spine neck|C3159206|[celc]|["neck"-tx-26-"NECK"-noun-0]|TX|4229/4|
00000000|MMI|4.81|hold - Data Operation|C3853841|[ftcn]|["hold"-tx-4-"HOLD"-verb-0]|TX|786/4|
00000000|MMI|4.81|per second|C0565930|[qnco]|["/s"-tx-12-"("-noun-0]|TX|2533/1|
00000000|MMI|4.81|percent positive cells|C0439178|[qnco]|["% Positive"-tx-19-"positive"-noun-0]|TX|3694/8|
00000000|MMI|4.81|quetiapine|C0123091|[orch,phsu]|["QUETIAPINE"-tx-6-"QUETIAPINE"-noun-0]|TX|1311/10|
00000000|MMI|4.81|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-15-"TREATMENTS/PROCEDURES"-noun-0]|TX|3145/21|
00000000|MMI|4.81|warming process|C0687712|[npop]|["warm"-tx-36-"Warm"-adj-0]|TX|4430/4|
00000000|MMI|3.69|Give - dosing instruction imperative|C1947971|[ftcn]|["Give"-tx-47-"giving"-verb-0]|TX|4873/6|
00000000|MMI|3.55|Asclepias tuberosa|C0697038|[plnt]|["Pleurisy"-tx-16-"pleuritic"-adj-0]|TX|3470/9|
00000000|MMI|3.53|Non-pitting edema|C1265804|[fndg]|["Non-pitting oedema"-tx-38-"non-pitting edema"-noun-0]|TX|4460/17|
00000000|MMI|3.51|g.m|C0456715|[qnco]|["m g"-tx-29-"m g"-noun-0]|TX|4306/1,4310/1|
00000000|MMI|3.48|3-4|C3840617|[fndg]|["3-4"-tx-1-"3/4"-fraction-0]|TX|16/3|
00000000|MMI|3.48|3/4|C0442757|[fndg]|["3 4"-tx-1-"3/4"-fraction-0]|TX|16/3|
00000000|MMI|3.48|Heart sounds:Find:Pt:Heart:Nom|C4050434|[clna]|["Heart sounds"-tx-28-"heart sounds"-noun-0]|TX|4282/12|
00000000|MMI|3.48|MR vaccine|C0694746|[imft,phsu]|["M/R"-tx-29-"m/r"-noun-0]|TX|4306/3|
00000000|MMI|3.48|Medication.discharge|C0806915|[fndg]|["Discharge medications"-tx-4-"DISCHARGE MEDICATIONS"-noun-0]|TX|331/21|
00000000|MMI|3.47|Domestic activities|C0441660|[dora]|["house activity"-tx-12-"House ACTIVITY"-noun-0]|TX|2456/5,2481/8|
00000000|MMI|3.44|Breast surgery specialty|C0851312|[prog]|["Breast operations"-tx-15-"breast OPERATIONS"-noun-0]|TX|3097/6,3107/10|
00000000|MMI|3.44|Intermittent pain|C1282310|[sosy]|["Intermittent pain"-tx-20-"intermittent pain"-noun-0]|TX|3783/12,3800/4|
00000000|MMI|3.44|Operation on breast|C3714726|[topp]|["Breast operations NOS"-tx-15-"breast OPERATIONS"-noun-0]|TX|3097/6,3107/10|
00000000|MMI|3.42|Add - instruction imperative|C1883712|[ftcn]|["Addition"-tx-23-"addition"-adv-0]|TX|3988/8|
00000000|MMI|3.42|Admission activity|C0809949|[hlca]|["Admission"-tx-15-"Admission"-noun-0]|TX|2770/9|
00000000|MMI|3.42|Arylsulfatase A, human|C3853627|[aapp,enzy]|["ASA"-tx-48-"ASA"-noun-0]|TX|4951/3|
00000000|MMI|3.42|Attending (action)|C1999232|[ftcn]|["attending"-tx-2-"Attending"-noun-0]|TX|242/9|
00000000|MMI|3.42|Attending (provider role)|C1547429|[prog]|["Attending"-tx-2-"Attending"-noun-0]|TX|242/9|
00000000|MMI|3.42|CETRIMONIUM BROMIDE|C0951233|[hops,orch]|["CTAB"-tx-30-"CTAB"-noun-0]|TX|4328/4|
00000000|MMI|3.42|Chemotherapy Regimen|C0392920|[topp]|["Chemotherapy, NOS"-tx-12-"Chemotherapy"-noun-0]|TX|2205/12|
00000000|MMI|3.42|In addition to|C0332287|[ftcn]|["Addition"-tx-23-"addition"-adv-0]|TX|3988/8|
00000000|MMI|3.42|Instructions:Text:Point in time:^Patient:Narrative|C3263700|[clna]|["Instructions"-tx-4-"Instructions"-noun-0]|TX|818/12|
00000000|MMI|3.42|Laundry|C1830412|[dora]|["Laundry"-tx-15-"laundry"-noun-0]|TX|3452/7|
00000000|MMI|3.42|Laundry:-:Point in time:^Patient:-|C1830411|[clna]|["Laundry"-tx-15-"laundry"-noun-0]|TX|3452/7|
00000000|MMI|3.42|M NOS ANTIBODY|C0369637|[aapp,imft]|["M NOS"-tx-59-"M"-noun-0]|TX|5711/1|
00000000|MMI|3.42|M+ (tumor staging)|C0441923|[inpr]|["M+"-tx-59-"M"-noun-0]|TX|5711/1|
00000000|MMI|3.42|Pain in lower limb|C0023222|[sosy]|["LEG PAIN"-tx-20-"leg pain"-noun-0]|TX|3796/8|
00000000|MMI|3.42|Status|C0449438|[qlco]|["Status"-tx-4-"STATUS"-noun-0]|TX|285/6|
00000000|MMI|3.41|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-15-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2703/9,2723/9|
00000000|MMI|3.41|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-15-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2703/9,2723/9|
00000000|MMI|3.39|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-15-"DISCHARGE DIAGNOSIS"-noun-0]|TX|2713/19|
00000000|MMI|3.38|Anemia in neoplastic disease|C0475534|[dsyn]|["Anemia in neoplastic disease"-tx-12-"Anemia in Neoplastic Disease"-noun-0]|TX|2311/28|
00000000|MMI|3.38|Entered|C1521975|[qlco]|["Entered"-tx-59-"ENTERED"-verb-0]|TX|5684/7|
00000000|MMI|3.38|Stable Disease|C0677946|[fndg]|["Stable condition"-tx-21-"stable condition"-noun-0]|TX|3908/16|
00000000|MMI|3.38|Stable chronic Graft vs Host Disease|C3538874|[fndg]|["Stable condition"-tx-21-"stable condition"-noun-0]|TX|3908/16|
00000000|MMI|3.37|97|C0439073|[inpr]|["97"-tx-24-"97"-real_number-0]|TX|4078/2|
00000000|MMI|3.37|>97|C0439082|[qnco]|[">97"-tx-24-"97"-real_number-0]|TX|4078/2|
00000000|MMI|3.37|Back structure, excluding neck|C1995000|[blor]|["Back, NOS"-tx-21-"back"-noun-0]|TX|3881/4|
00000000|MMI|3.37|Back structure, including back of neck|C0460009|[blor]|["Back"-tx-21-"back"-noun-0]|TX|3881/4|
00000000|MMI|3.37|Changed status|C0443172|[qnco]|["change"-tx-40-"change"-noun-0]|TX|4534/6|
00000000|MMI|3.37|Changing|C0392747|[ftcn]|["Change"-tx-40-"change"-noun-0]|TX|4534/6|
00000000|MMI|3.37|Delta (difference)|C1705241|[qnco]|["Change"-tx-40-"change"-noun-0]|TX|4534/6|
00000000|MMI|3.37|Dietary Supplementation|C0242297|[topp]|["Supplementation"-tx-44-"supplementation"-noun-0]|TX|4757/15|
00000000|MMI|3.37|Disposition|C0743223|[idcn]|["Disposition"-tx-4-"DISPOSITION"-noun-0]|TX|303/11|
00000000|MMI|3.37|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-4-"DISPOSITION"-noun-0]|TX|303/11|
00000000|MMI|3.37|Dorsal|C0205095|[spco]|["BACK"-tx-21-"back"-noun-0]|TX|3881/4|
00000000|MMI|3.37|HP gene|C1415692|[gngm]|["Bp"-tx-24-"BP"-noun-0]|TX|4092/2|
00000000|MMI|3.37|HP wt Allele|C1708288|[gngm]|["BP"-tx-24-"BP"-noun-0]|TX|4092/2|
00000000|MMI|3.37|Issue (document)|C1706387|[inpr]|["Issue"-tx-48-"issues"-noun-0]|TX|4937/6|
00000000|MMI|3.37|Lymphotoxin-Alpha, human|C3887647|[aapp,imft]|["LT"-tx-4-"lt"-noun-0]|TX|812/2|
00000000|MMI|3.37|Nutrition function|C1442959|[orgf]|["Nutrition"-tx-53-"nutrition"-noun-0]|TX|5146/9|
00000000|MMI|3.37|Nutrition outcomes|C0518896|[inpr]|["Nutrition"-tx-53-"nutrition"-noun-0]|TX|5146/9|
00000000|MMI|3.37|Patterns|C0449774|[spco]|["Pattern"-tx-40-"pattern"-noun-0]|TX|4515/7|
00000000|MMI|3.37|Problem|C0033213|[fndg]|["Issue"-tx-48-"issues"-noun-1]|TX|4937/6|
00000000|MMI|3.37|Structure of left thigh|C0230426|[bpoc]|["LT"-tx-4-"lt"-noun-0]|TX|812/2|
00000000|MMI|3.37|T prime|C2603360|[clna]|["T'"-tx-24-"T"-noun-0]|TX|4076/1|
00000000|MMI|3.35|Entire lower leg, from knee to ankle|C1285009|[blor]|["Leg"-tx-20-"leg"-noun-0]|TX|3796/3|
00000000|MMI|3.35|GEN1 gene|C2239486|[gngm]|["Gen"-tx-24-"GEN"-noun-0]|TX|4133/3|
00000000|MMI|3.35|Planned|C1301732|[ftcn]|["Plan"-tx-59-"PLAN"-noun-0]|TX|5613/4|
00000000|MMI|3.35|Treatment Plan|C0599880|[inpr]|["Plan"-tx-59-"PLAN"-noun-0]|TX|5613/4|
00000000|MMI|3.35|Anti factor Xa measurement|C0427612|[lbpr]|["Anti factor Xa level"-tx-42-"anti-factor Xa level"-noun-0]|TX|4634/20|
00000000|MMI|3.35|Basal Diet|C2983588|[food]|["DIET"-tx-12-"DIET"-noun-0]|TX|2413/4|
00000000|MMI|3.35|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-12-"DIET"-noun-0]|TX|2413/4|
00000000|MMI|3.35|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-12-"DIET"-noun-0]|TX|2413/4|
00000000|MMI|3.35|ZFP36 wt Allele|C3539814|[gngm]|["TTP"-tx-31-"TTP"-noun-0]|TX|4356/3|
00000000|MMI|3.34|Dose number|C1115464|[qnco]|["Dose number"-tx-8-"Number Doses"-noun-0]|TX|1585/6,1595/5|
00000000|MMI|3.34|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-2-"Service"-noun-0]|TX|108/7|
00000000|MMI|3.34|Services|C0557854|[ocac]|["Service"-tx-2-"Service"-noun-0]|TX|108/7|
00000000|MMI|3.34|Software Service|C2825316|[mnob]|["Service"-tx-2-"Service"-noun-0]|TX|108/7|
00000000|MMI|3.33|Anxiety Scale (BASC-2)|C4050613|[inpr]|["Anxiety"-tx-6-"Anxiety"-noun-0]|TX|1361/7|
00000000|MMI|3.33|End|C0444930|[spco]|["End"-tx-62-"END"-noun-0]|TX|5766/3|
00000000|MMI|3.33|Negative|C0205160|[qlco]|["Negative"-tx-18-"negative"-noun-0]|TX|3574/8|
00000000|MMI|3.33|Negative Charge|C2825491|[qlco]|["Negative"-tx-18-"negative"-noun-0]|TX|3574/8|
00000000|MMI|3.33|Negative Finding|C1513916|[fndg]|["NEGATIVE"-tx-18-"negative"-noun-0]|TX|3574/8|
00000000|MMI|3.33|Negative Number|C2825415|[cnce]|["Negative"-tx-18-"negative"-noun-0]|TX|3574/8|
00000000|MMI|3.33|Responsible to|C1273518|[fndg]|["Responsible"-tx-15-"Responsible"-adj-0]|TX|2734/11|
00000000|MMI|3.33|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-62-"END"-noun-0]|TX|5766/3|
00000000|MMI|3.33|Worse|C1457868|[fndg]|["worsen"-tx-16-"worsens"-verb-0]|TX|3484/7|
00000000|MMI|3.33|Worsening pattern|C0332271|[qlco]|["worsens"-tx-16-"worsens"-verb-0]|TX|3484/7|
00000000|MMI|3.31|ANTICOAGULATION (finding)|C2919015|[fndg]|["ANTICOAGULATION"-tx-42-"Anticoagulation"-noun-0]|TX|4603/15|
00000000|MMI|3.31|Anticoagulation Therapy|C0003281|[topp]|["anticoagulation"-tx-42-"Anticoagulation"-noun-0]|TX|4603/15|
00000000|MMI|3.31|Conditional|C1701901|[qlco]|["Contingent"-tx-2-"CONTINGENT"-noun-0]|TX|164/10|
00000000|MMI|3.31|Decreased Coagulation Activity [PE]|C3537050|[phsf]|["Anticoagulation"-tx-42-"Anticoagulation"-noun-0]|TX|4603/15|
00000000|MMI|3.31|Deferred|C0205421|[tmco]|["Defer"-tx-47-"defer"-verb-0]|TX|4824/5|
00000000|MMI|3.31|Feeling relief|C0564405|[fndg]|["Relief"-tx-17-"relief"-noun-0]|TX|3517/6|
00000000|MMI|3.31|Negative Regulation of Coagulation|C2917212|[phsf]|["Anticoagulation"-tx-42-"Anticoagulation"-noun-0]|TX|4603/15|
00000000|MMI|3.31|Patient in hospital|C0701159|[fndg]|["HOSPITALIZED"-tx-58-"hospitalized"-verb-0]|TX|5372/12|
00000000|MMI|3.31|Return to (contextual qualifier) (qualifier value)|C0332156|[qlco]|["Return"-tx-58-"return"-noun-0]|TX|5503/6|
00000000|MMI|3.30|Only - dosing instruction fragment|C1720467|[inpr]|["Only"-tx-19-"only"-adv-0]|TX|3712/4|
00000000|MMI|3.30|Singular|C0205171|[qnco]|["Only"-tx-19-"only"-adv-0]|TX|3712/4|
00000000|MMI|3.30|Small|C0700321|[qnco]|["SMALL"-tx-19-"small"-adj-0]|TX|3722/5|
00000000|MMI|3.30|Blood Clot|C0302148|[bdsu]|["Clot"-tx-58-"clot"-noun-0]|TX|5414/4|
00000000|MMI|3.30|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-15-"RESUME"-noun-0]|TX|3194/6|
00000000|MMI|3.30|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-15-"RESUME"-noun-0]|TX|3194/6|
00000000|MMI|3.30|Side|C0441987|[spco]|["Side"-tx-15-"side"-noun-0]|TX|3384/4|
00000000|MMI|3.30|Used by|C1273517|[fndg]|["used"-tx-2-"USED"-verb-1]|TX|213/4|
00000000|MMI|3.30|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-15-"RESUME"-noun-0]|TX|3194/6|
00000000|MMI|3.29|Disease classification level|C0456079|[clas]|["Level"-tx-12-"level"-noun-0]|TX|2248/5|
00000000|MMI|3.29|Floor - story of building|C1547707|[geoa]|["Level"-tx-12-"level"-noun-0]|TX|2248/5|
00000000|MMI|3.29|Level|C2946261|[phsu]|["Level"-tx-12-"level"-noun-0]|TX|2248/5|
00000000|MMI|3.29|Levels (qualifier value)|C0441889|[qlco]|["Level"-tx-12-"level"-noun-0]|TX|2248/5|
00000000|MMI|3.29|Lactulose.PO|C2735286|[orch,phsu]|["Lactulose.PO"-tx-4-"LACTULOSE PO"-noun-0]|TX|715/9,740/2|
00000000|MMI|3.29|Per Deciliter|C3642216|[qnco]|["/dL"-tx-12-"dL"-noun-0]|TX|2278/2|
00000000|MMI|3.28|Discontinued|C1444662|[fndg]|["D/C"-tx-2-"D/C"-noun-1]|TX|200/3|
00000000|MMI|3.28|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-2-"D/C"-noun-0]|TX|200/3|
00000000|MMI|3.28|Take|C1515187|[hlca]|["Take"-tx-4-"Take"-verb-0]|TX|700/4|
00000000|MMI|3.25|Active|C0205177|[ftcn]|["Active"-tx-48-"active"-adj-0]|TX|4930/6|
00000000|MMI|3.25|Active License|C3888249|[qlco]|["Active"-tx-48-"active"-adj-0]|TX|4930/6|
00000000|MMI|3.25|Causing|C0678227|[ftcn]|["Causing"-tx-15-"Causing"-adj-0]|TX|2762/7|
00000000|MMI|3.25|Diagnosis Type - Final|C1546485|[idcn]|["Final"-tx-1-"FINAL"-adj-0]|TX|32/5|
00000000|MMI|3.25|End-stage|C0205088|[qlco]|["Final"-tx-1-"FINAL"-adj-0]|TX|32/5|
00000000|MMI|3.25|Final|C3853528|[tmco]|["Final"-tx-1-"FINAL"-adj-0]|TX|32/5|
00000000|MMI|3.25|Increase|C0442805|[ftcn]|["Increased"-tx-58-"increased"-adj-0]|TX|5539/9|
00000000|MMI|3.25|Increased|C0205217|[qnco]|["Increased"-tx-58-"increased"-adj-0]|TX|5539/9|
00000000|MMI|3.25|Psychiatric problem|C1306597|[mobd]|["psych"-tx-55-"PSYCH"-noun-0]|TX|5208/5|
00000000|MMI|3.25|Pump Device Component|C1706421|[mnob]|["Pump"-tx-49-"PUMP"-noun-0]|TX|4957/4|
00000000|MMI|3.25|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-12-"PUO"-noun-0]|TX|2296/3|
00000000|MMI|3.25|Yes (indicator)|C1705108|[cnce]|["YES"-tx-2-"YES"-noun-0]|TX|238/3|
00000000|MMI|3.25|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-2-"YES"-noun-0]|TX|238/3|
00000000|MMI|3.25|active (HL7 RoleLink)|C3853793|[idcn]|["active"-tx-48-"active"-adj-0]|TX|4930/6|
00000000|MMI|3.25|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-59-"dictated"-adj-0]|TX|5667/8|
00000000|MMI|3.25|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-59-"dictated"-adj-0]|TX|5667/8|
00000000|MMI|3.25|pump (device)|C0182537|[medd]|["Pump"-tx-49-"PUMP"-noun-0]|TX|4957/4|
00000000|MMI|3.24|Border of rib|C0582240|[blor]|["Costal margin"-tx-31-"costal margin"-noun-0]|TX|4337/13|
00000000|MMI|3.23|Character String Data Type|C3272372|[inpr]|["ST"-tx-40-"ST"-adj-0]|TX|4528/2|
00000000|MMI|3.23|Distant|C0443203|[spco]|["DISTANT"-tx-28-"Distant"-adj-0]|TX|4274/7|
00000000|MMI|3.23|Emotional Strain|C2987481|[menp]|["Strain"-tx-40-"strain"-noun-1]|TX|4508/6|
00000000|MMI|3.23|Ferrum metallicum, Homeopathic preparation|C1166521|[phsu]|["iron"-tx-44-"iron"-noun-0]|TX|4752/4|
00000000|MMI|3.23|Full|C0443225|[qlco]|["Full"-tx-4-"Full"-adj-0]|TX|293/4|
00000000|MMI|3.23|Iron Drug Class|C3714701|[phsu]|["IRON"-tx-44-"iron"-noun-0]|TX|4752/4|
00000000|MMI|3.23|MYOTONIC DYSTROPHY 1|C3250443|[dsyn]|["DM"-tx-51-"DM"-noun-0]|TX|5053/2|
00000000|MMI|3.23|Microbiology subtype strains|C0456178|[qlco]|["strain"-tx-40-"strain"-noun-0]|TX|4508/6|
00000000|MMI|3.23|Muscle strain|C0080194|[inpo]|["Strain"-tx-40-"strain"-noun-1]|TX|4508/6|
00000000|MMI|3.23|Organism Strain|C1518614|[orgm]|["STRAIN"-tx-40-"strain"-noun-0]|TX|4508/6|
00000000|MMI|3.23|Randomization Validation|C3889272|[resa]|["RV"-tx-40-"RV"-noun-0]|TX|4505/2|
00000000|MMI|3.23|Rehabilitation - specialty|C1306847|[bmod]|["Rehabilitation"-tx-4-"Rehabilitation"-noun-0]|TX|316/14|
00000000|MMI|3.23|Treated with|C0332293|[topp]|["TW"-tx-40-"TW"-noun-0]|TX|4531/2|
00000000|MMI|3.23|over sedation|C0542127|[fndg]|["Oversedated"-tx-4-"oversedated"-adj-0]|TX|795/11|
00000000|MMI|3.22|1+|C3816745|[fndg]|["1+"-tx-37-"1"-integer-0]|TX|4444/1|
00000000|MMI|3.22|1+ Score|C2827734|[qnco]|["1+"-tx-37-"1"-integer-0]|TX|4444/1|
00000000|MMI|3.22|1+ Score, WHO|C2981698|[clas]|["1+"-tx-37-"1"-integer-0]|TX|4444/1|
00000000|MMI|3.22|50%|C3842586|[fndg]|["50%"-tx-4-"50"-integer-0]|TX|915/2|
00000000|MMI|3.22|<50|C3843766|[fndg]|["<50"-tx-4-"50"-integer-0]|TX|915/2|
00000000|MMI|3.22|Brother - courtesy title|C1704648|[cnce]|["Br."-tx-37-"BR"-noun-0]|TX|4449/2|
00000000|MMI|3.22|Glipizide 5 MG|C0986241|[clnd]|["Glipizide 5 MG"-tx-4-"GLIPIZIDE 5 MG"-noun-0]|TX|561/14|
00000000|MMI|3.22|Ibuprofen 600 MG|C0986667|[clnd]|["Ibuprofen 600 MG"-tx-4-"IBUPROFEN 600 MG"-noun-0]|TX|633/16|
00000000|MMI|3.22|Intermittent|C0205267|[tmco]|["INTERMITTENT"-tx-20-"intermittent"-adj-0]|TX|3783/12|
00000000|MMI|3.22|Kilogram|C0439209|[qnco]|["kg"-tx-24-"kg"-noun-0]|TX|4130/2|
00000000|MMI|3.22|Metastatic to|C0036525|[ftcn]|["Metastatic"-tx-15-"metastatic"-adj-0]|TX|3086/10|
00000000|MMI|3.22|Microgram per Inhalation|C2827876|[qnco]|["mcg/inh"-tx-6-"MCG INH"-noun-0]|TX|1268/7|
00000000|MMI|3.22|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-59-"Stable"-adj-0]|TX|5600/6|
00000000|MMI|3.22|Per Kilogram|C4054209|[qnco]|["/kg"-tx-24-"kg"-noun-0]|TX|4130/2|
00000000|MMI|3.22|Stable status|C0205360|[qlco]|["STABLE"-tx-59-"Stable"-adj-0]|TX|5600/6|
00000000|MMI|3.22|TXNRD1 wt Allele|C3811249|[gngm]|["TR"-tx-38-"Tr"-noun-0]|TX|4457/2|
00000000|MMI|3.22|TXNRD2 wt Allele|C3811250|[gngm]|["TR"-tx-38-"Tr"-noun-0]|TX|4457/2|
00000000|MMI|3.22|Thioredoxin Reductase 1, Cytoplasmic|C3814410|[aapp,enzy]|["TR"-tx-38-"Tr"-noun-0]|TX|4457/2|
00000000|MMI|3.22|Tumor Results Domain|C3814152|[inpr]|["TR"-tx-38-"Tr"-noun-0]|TX|4457/2|
00000000|MMI|3.22|Wild Type Unspecified - zebrafish|C2700323|[fish]|["WT"-tx-24-"Wt"-noun-0]|TX|4123/2|
00000000|MMI|3.22|chronic|C0205191|[tmco]|["CHRONIC"-tx-20-"chronic"-adj-0]|TX|3775/7|
00000000|MMI|3.22|trazodone 50 mg|C2945736|[clnd]|["trazodone 50 mg"-tx-4-"TRAZODONE 50 MG"-noun-0]|TX|871/15|
00000000|MMI|3.21|Deep vein thrombosis of lower limb|C0340708|[dsyn]|["leg dvt"-tx-20-"leg DVT"-noun-0]|TX|3849/7|
00000000|MMI|3.21|20%|C3842589|[fndg]|["20%"-tx-12-"20"-integer-0]|TX|2401/2|
00000000|MMI|3.21|4+ Answer to question|C3838679|[fndg]|["4+"-tx-9-"4"-integer-0]|TX|1826/1|
00000000|MMI|3.21|Bony|C0443157|[ftcn]|["Bony"-tx-31-"bony"-adj-0]|TX|4351/4|
00000000|MMI|3.21|Teaching principal|C0401925|[prog]|["Principal"-tx-15-"PRINCIPAL"-adj-0]|TX|2703/9|
00000000|MMI|3.21|Anti-Drug Antibody|C3811629|[aapp,imft]|["ADA"-tx-12-"ADA"-noun-0]|TX|2464/3|
00000000|MMI|3.21|CA8 gene|C1413051|[gngm]|["CALS"-tx-12-"cals"-noun-0]|TX|2473/4|
00000000|MMI|3.21|Genus Ada|C1060325|[plnt]|["Ada"-tx-12-"ADA"-noun-0]|TX|2464/3|
00000000|MMI|3.21|Nutrition, Calories|C1556156|[qnco]|["cals"-tx-12-"cals"-noun-0]|TX|2473/4|
00000000|MMI|3.21|Study Day|C2826182|[tmco]|["DY"-tx-12-"dy"-noun-0]|TX|2478/2|
00000000|MMI|3.21|kilocalorie|C0439259|[qnco]|["Cal"-tx-12-"cals"-noun-0]|TX|2473/4|
00000000|MMI|3.21|0%|C3842591|[fndg]|["0%"-tx-2-"0"-integer-0]|TX|92/1|
00000000|MMI|3.21|60%|C3842585|[fndg]|["60%"-tx-2-"60"-integer-0]|TX|86/2|
00000000|MMI|3.21|Cholesterol measurement test|C0201950|[lbpr]|["CHOL"-tx-12-"chol"-noun-0]|TX|2431/4|
00000000|MMI|3.21|Every six hours|C0585325|[tmco]|["Q6H"-tx-6-"Q6H"-noun-0]|TX|1178/3|
00000000|MMI|3.21|House (environment)|C2003847|[mnob]|["House"-tx-12-"House"-noun-0]|TX|2419/5|
00000000|MMI|3.21|Nausea Adverse Event|C1963179|[patf]|["Nausea"-tx-6-"Nausea"-noun-0]|TX|1186/6|
00000000|MMI|3.21|SAT1 protein, human|C2744672|[aapp,enzy]|["SAT"-tx-12-"sat"-noun-0]|TX|2440/3|
00000000|MMI|3.21|SAT1 wt Allele|C1705827|[gngm]|["SAT"-tx-12-"sat"-noun-0]|TX|2440/3|
00000000|MMI|3.20|Alert|C3665546|[ftcn]|["Alert"-tx-9-"Alert"-noun-0]|TX|1893/5|
00000000|MMI|3.20|Alert:Type:Point in time:^Patient:Nominal|C3669039|[clna]|["Alert"-tx-9-"Alert"-noun-0]|TX|1893/5|
00000000|MMI|3.20|Consciousness clear|C0239110|[fndg]|["ALERT"-tx-9-"Alert"-noun-0]|TX|1893/5|
00000000|MMI|3.20|Once a day, at bedtime|C1275563|[tmco]|["qHS"-tx-9-"QHS"-noun-0]|TX|1869/3|
00000000|MMI|3.20|Billion per Gram|C4055382|[qnco]|["10^9/g"-tx-12-"9 g 10"-adj-0]|TX|2272/1,2276/1,2284/2|
00000000|MMI|3.20|Room of building - Study|C0557651|[mnob]|["Study"-tx-15-"Study"-noun-0]|TX|2752/5|
00000000|MMI|3.20|Study|C2603343|[resa]|["Study"-tx-15-"Study"-noun-0]|TX|2752/5|
00000000|MMI|3.20|Antacid Effects|C1383090|[phsf]|["Antacid"-tx-4-"antacid"-noun-0]|TX|553/7|
00000000|MMI|3.20|Cough Adverse Event|C1961131|[fndg]|["Cough"-tx-4-"cough"-noun-0]|TX|627/5|
00000000|MMI|3.20|Inhaler Dosing Unit|C1881212|[qnco]|["INHALER"-tx-4-"INHALER"-noun-0]|TX|397/7|
00000000|MMI|3.20|Picofarad (unit of measure)|C1882376|[qnco]|["Puff"-tx-4-"PUFF"-noun-0]|TX|407/4|
00000000|MMI|3.20|Puff unit dose|C1533107|[qnco]|["PUFF"-tx-4-"PUFF"-noun-0]|TX|407/4|
00000000|MMI|3.20|ribs on right side|C0947182|[bpoc]|["Ribs.right"-tx-15-"right ribs"-noun-0]|TX|3378/5,3396/4|
00000000|MMI|3.19|PRN medicine|C3166225|[clna]|["PRN Drugs"-tx-4-"PRN Drug"-noun-0]|TX|657/3,671/4|
00000000|MMI|3.19|Total Amyloid Precursor Protein Measurement|C3887695|[lbpr]|["APPT"-tx-59-"appts"-noun-0]|TX|5641/5|
00000000|MMI|3.19|X-Prep Liquid|C0308145|[clnd]|["X-Prep Liquid"-tx-4-"SENNA LIQUID"-noun-0]|TX|846/12|
00000000|MMI|3.18|Dosage|C0178602|[qnco]|["DOSE"-tx-57-"dose"-noun-0]|TX|5316/4|
00000000|MMI|3.18|Rib pain|C0574068|[sosy]|["Rib pain"-tx-15-"rib pain"-noun-0]|TX|3430/8|
00000000|MMI|3.18|Unit dose|C0869039|[qnco]|["Dose"-tx-57-"dose"-noun-0]|TX|5316/4|
00000000|MMI|3.18|history of - * (non-specific)|C0455483|[fndg]|["h o"-tx-15-"h/o"-noun-0]|TX|3234/3|
00000000|MMI|3.18|Behavior Rating Inventory of Executive Function|C4050216|[inpr]|["BRIEF"-tx-15-"BRIEF"-adj-0]|TX|3188/5|
00000000|MMI|3.18|Brief|C1879313|[tmco]|["Brief"-tx-15-"BRIEF"-adj-0]|TX|3188/5|
00000000|MMI|3.18|Shortened|C1282927|[qlco]|["brief"-tx-15-"BRIEF"-adj-0]|TX|3188/5|
00000000|MMI|3.18|CYGB gene|C1424337|[gngm]|["HGB"-tx-12-"Hgb"-noun-0]|TX|2244/3|
00000000|MMI|3.18|Hemoglobin concentration result|C0019029|[lbtr]|["HgB"-tx-12-"Hgb"-noun-0]|TX|2244/3|
00000000|MMI|3.18|Hemoglobin measurement|C0518015|[lbpr]|["HGB"-tx-12-"Hgb"-noun-0]|TX|2244/3|
00000000|MMI|3.18|Known|C0205309|[qlco]|["Known"-tx-12-"known"-adj-0]|TX|2238/5|
00000000|MMI|3.18|Pharmaceutical Preparations|C0013227|[phsu]|["Medication"-tx-24-"medication"-noun-0]|TX|4172/10|D26
00000000|MMI|3.18|Time (foundation metadata concept)|C3541383|[tmco]|["Time"-tx-12-"time"-noun-0]|TX|2257/4|
00000000|MMI|3.18|medication - HL7 publishing domain|C3244316|[ftcn]|["medication"-tx-24-"medication"-noun-0]|TX|4172/10|
00000000|MMI|3.18|microgram|C0439211|[qnco]|["mcg"-tx-12-"MCG"-noun-0]|TX|2158/3|
00000000|MMI|3.18|miscellaneous Crenarchaeota group|C3463985|[arch]|["MCG"-tx-12-"MCG"-noun-0]|TX|2158/3|
00000000|MMI|3.18|event cycle|C1511572|[tmco]|["Cycle"-tx-12-"Cycle"-noun-0]|TX|2357/5|
00000000|MMI|3.17|Concept model range (foundation metadata concept)|C3542016|[inpr]|["Range"